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ABSTRACT
Cytoch ro me c oxidase (ferrocytochrome c : 02
oxidoreductase ; EC 1.9. 3.1) is the terminal enzyme in the
mitochondrial electron transport chain, catalyzing the transfer of
electrons from ferrocytochrome c to molecular oxygen. The
effects of two large amphiphilic molecules .. valinomycin and
dibucaine upon the spectra of the isolated enzyme and upon the
activity of both isolated enzyme and enzyme in membrane
systems are investigated by using spectrophotometric and oxygen
electrode techniques.
The results show that both valinomycin and dibucaine
change the Soret region of the spectrum and cause a partial
inhibition in a concentration range higher than that in which they
act as ionophores. It is concluded that both valinomycin and
dibucain~ binding induce a conformational change of the protein
structure which modifies the spectrum of the a3 CUB centre and
diminishes the rate of electron transfer between cytochrome a
and the binuclear centre.
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INTRODUCTION
I. General features of cytochrome oxidase
Cytochrome c oxidase (ferrocytochromec: 02
oxidoreductase;EC 1.9.3.1 )is the terminal enzyme of the electron
transport chain located in the eukaryoticinner mitochondrial
membrane and the plasma membrane of someprokaryotes. It
catalyzes a four-electron reduction of oxygen to water and the
oxidation of ferrocytochrome ,0 • As the diagram in Fig.1 shows,
electron,s flow from cytochrome c bound at the external("C") face
to an oxygen reduction site(MitcheU 1966a) and at the same
time a proton electrochemical potential is ge,neratedacross the
membrane by a combination of the consumption of matrix protons
during the reduction of oxygen and the translocation of protons
from matrix to intermembrane space(Wikstrom 1977, Chan and Li
1990). The overall reaction can be described as follows :
4 cytoc)hrome 02+ + 4H+ +02----+ 4 cytochrome c3+ + 2H20
Eq. 1
This proton electrochemical potential is composed of a pH
gradient(alkaline inside) and a membrane potential (negative
inside), and is utilized to drive the thermodynamically
unfavourable synthesis of ATP ,via the F1 Fo ATP synthetase.
Cytochrome coxidasecan be purified from many sources,
such as bacteria, yeastandma·mmafs.Cytochrome oxidase from
12
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Fig. 1. A model for cytochrome coxidase function in 13
membranes
Adopted from Fig. 1(Cooper 1990). Cand Msides are referring to
cytosol side and mitochondrial matrix side respectively. The "+"
side refers to positively charged side , which in this case is the
"C" side. The ".If side refers to negatively charged side, which in
this case is the tiM" side.
mammals , especially that from bovine heart, has been most 1 4
extensively studied. It conta.ins 13 polypeptide subunits
(Kadenbach et a~83) and has a molecular weight of 200,000 per
monomer. It can also exist as a dime~(Wikstrom et al 1981}. The
.........-.
three heaviest polypeptides , subunits 1,llandlllare coded by
mitochondrial DNA . The smaller polypeptides are coded by
nuclear DNA. Chemical labelling, cross-link:ing and antibody
binding have been used to ,probe subunit structure, orientation in
the membrane and interrelationships . The results as reviewed by
Cooper at at (1991 ) are summarized in the scheme ·of Fig. 2.
Fig. 2 shows how subunits I and If I are buried in the
hydrophobic membrane and subunit It binds o. All the subunits
are transmembranous , except fo·r subunit V which faces the
matrix and subunits Viand VII which face the cytoplasm.
Theaukaryotic enzyme contains two iron-containing haem A
groups and two functional copper atoms, CUA and CUB (Wikstrom
et al 1981)1> . The twohaems are in very different
environmen~Keilin and Hartree 1939) : haem a is usually low
'----
spin and does not bind ligands while haem as is usually high spin
and reacts with various ligands. The two copper atoms are
integral parts of the electron tra.nsfe.r apparatus: CUAaccepts
electrons directly from cytochrome 0 (Hill 1990) and CUB forms
part of the 02 reduction site with haem a3. The stoichiometry and
function of a possible third copper atom "CuX II (Steffens et at
1987) are uncertain. The roles of one zinc and one magnesium
atom (Einarsdottir and Caughey 1984, 1985) have also not been
determined, although Yewey and CaUghe~987) suggested that
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Fig. 2. Membrane orientation of cytochrome c oxidase 1 5
Adopted from Fig.1 (Cooper al 1991). Different patches
represent different subunits and their relative-positions when the
enzyme is located in membrane. Subunits IX, X, XI, XII and XIII are
omitted for clarity.
the intrinsic magnesium might be essential for ATP binding. 1 6
Direct localizatio·n of the prosthetic groups has been harder
to achieve as the haems and coppers are labile under the
dissociating conditions used to separate subunits via SDS PAGE or
similar means. But several pieces of evidence indicate that
subunits I and II contain aU four redox centers. Firstly , subunit II
has an amino acid sequence homologous to that of copper
proteins of the plastocyanin type in plantphotosynthesis(Colman
at at 1978). So the binding site for CUAis presumably in subunit
II. This leaves cytochrome a and the binuclear canter on subunit L
Secondly, bacterial ass-type cytochromeoxidaseshave a
relatively simple subunit composition..ln all the bacteria f.rom
which such an oxidase has been isolated , no more than four
subunits have been found (Poole 1988) . The isolated Paracoccus
oxidase has two subunits which resemble the two largest
s·ubunitsin the mitochondrial oxidase in their hydrophobicity ,
immunological cross-reactivity(Ludwig 1982)and sequence
homology(Steffens at al 1987) .This enzyme is identical or
closely similar to the mitochondrial enzyme with respect to
electron transfer activity and sipectroscopic parameters(Albracht
etal 1980). A third loosely associated subunit in the Paracoccus
enzyme resembles subunit III of mammalian enzyme.
Chemically modified cytochrome c derivatives bind
covalently to subunit 11(8.i550n etal 1980). The hae<m cbinding
subunits of Thermus thermoph1/us (Buse et at 1989)and of
PS3(lshizuka at al 1990) are also partiaUy homologous with
eukaryotic subunit II. Soapparentfy su'bunit II contains a high
affinity cytochrome c binding site . Cytochrome c protects 1 7
subunit II from labelling with water-soluble
carbodiimides(Bisson and Montecucco 1982, Kadenbach and Stroh
1984) However, there was also some protection of subunits VII,
X, XI, and XIII . This could indicate substrate-induced
conformational change or that nuclear subunits play a facilitatory
role in cytochrome c binding.
Kinetic studies (Cooper 1990) reveal that the reaction does
not obey conventional Michaelis-Mentenkineticsat low ionic
strength. Non-linear Li1eweaver-Burk or Eadie-Hofstee plots are
o
obtained which consist a 'high-affinity, low turnover' phase and a
t
'low-affinity , high turnover 'phase. That led to the suggestion
that there was a second low affinity site for cytochrome c on
cytochrome C oxidase. Erecinska(1977) suggested that subunits V
and VI provide a low affinity site,. But as both the PS3 (Nicholls
and Sane 1984)andNitrobacteragilis enzymes(Fukumori and
Yamanaka 1984) possess akineticaUymeasurable low affinity
site, it appears likely that nuclear -coded subunits are not
essential parts of the binding site for a secon>d cytochrome c
molecule. The low affinity site may beca,mprised ,of phospholipid,
perhaps involving cardiolipin(Trivedi at at 1986).
Subunit III removal does not ·affectmetal content or enzyme
turnover(Yewey and Caughey 1987). It also does not dramatically
change electron transport or th,e optical spectrum(Penttiia etal
1979', Sarasteet al 1980) . Complete removal of subunit III by a-
chymotrypsin treatment of the bovine enzyme(Wilson and
Prochaska 1990), or cytochrome c affinity chromatography of rat
liver enzyme in the presence of lauryl maftoside(Thompson et al 1 8
1985) showed that the proton translocation was cut by 500/0. The
asa-type cytochrome c oxidase from Paracoccus ,which was
originally purified as a two subunit enzyme, had a proton
translocation stoichiometry of :0.6 H+le- (Poore 1988). DCCD, the
carboxyl-specific protein modifying reagent which binds a
glutamic acid residue in a part of the presumed proton
translocation channel in ATP synthetase( Hoppe and Sebald 1984),
also binds Glu-90, a conserved subunit III residue(Prochaska et al
1981). It is far more effective in inhibiting proto.n translocation
than electron transfer(Azzi at aI1984). This evidence indicates
that subunit III is important in modulation of proton
translocation .It is also suggested by Haltia et at (1989) to be
n.ecessary for the correct assembly of subunit land II.
The functions of the nuclear coded subunits are less clearly
understood. Bisson at at (19B?) showed that millim:olar
concentrations of ATP abolish the high affinity Km and linearize
the Eadie-Hofsteeplots.But labelling experiments with
carbodiimides showed no AT'P-induced change in cytochrome c
binding to subunit II , thepresumedhigh-affinityc binding site ,
and photo-affinity labelling showed that ATPbinds to sites on
subunits IV and VII. These results indicate that nuclear subunits
may undergo conformationalchang.e upon, binding ATP.
Kadenbach(1986) suggests that allosteric effectors such as AlP
can change the activity of cytoch'rome coxidaseby binding to
specific sites on nuclear-coded s,ubunits.
II. Conformations ·of cytochrome oxidase
In addition to fully oxidized ' resting' enzyme and fully
reduced enzyme, cytochromecoxidase can exist in transient
forms , such as 'pulsed' enzyme .This is produced by pulsing 02
into fully reduced enzyme in the absence of ferrocytochrome c.
Brunori et at (1979) demonstrated that the 'pulsed' oxidase
accepts four electrons in the conversion to the fully reduced
form, and the lag in intramolecular electron transfer is partially
or fully relieved. The spectral consequence of pulsing the enzyme
is a red shift of the Soretpeak. Pulsed enzyme shows a spectral
and kinetic resemblance to another transient form, the
'oxygenated' species(Wikstrom at aI1981). When pulsing the
enzyme , a major part _of the initial product can be the 'peroxy'
form which may contain bound oxygen and two more electrons
than the fully-oxidized from. This form then dG<cays to the later
'pulsed' form. (Moody et at 1991).
The cause of the spectral differences between the resting
and pulsed oxidase is unclear. 80S-PAGE electrophoresis does not
show signJficantdifference in subunitc>omposition between the
two species(Crinson 1991}. The spectral d'ifference must result
from changes in tertiary structure in the vicinity of the redox
centers. The similarity ·of the spectra of cyanocyto,chrome
oxidase and the initial pulsed form led to thaproposal that the
initial pulsed ('peroxy') enzyme has a low-spin cytochrome
a3 (Wrigglesworth at al 1988). The late-pulsed form may
represent an intermediate cytochrome a 3 species in the
1 9
relaxation of the initial pulsed enzyme to the resting state. 20
Raman spectroscoprlBabcock et al 1981)has revealed a low spin
--..
ferric haem a3, but MCDdata suggested a high spin state(Babcock
at at 1976). This discrepancy maybe due to the heterogeneity of
the initial pulsed enzyme, evidenced by the decay in minutes
from the initial 'peroxy' form to the late form which is stable for
several hours. Even the latter form is not homogeneous. Moody at
at (1991) claimed that in their 'fast' enzyme preparation, there
are at least two subpopulations, while crinsO~_991) also
reported that the relationship between the cytochrome a
reduction and the enzyme turnoverisbiphasic, indicating the
existence of a low-turnover and a high-turnover forms of the
enzyme. Pulsing the enzyme increases the proportion in the high-
turnover form. A sulphur atom from a nearby amino acid , a
partially reduced oxygen atom,and a water molecule may be the
bridging ligands between haem a3 and CUB in the resting, initial
pulsed('peroxy'), and late-pulsed enzymes respectively(Crinson
1991).
It has been generally accepted that the oxidized ('resting')
enzyme contains two magneticallyisofated spin 3=1/2 centers,
which correspond to the low spin ferric haem a and cupric CUA
respectively(Wikstrom at al 1981). It also contains a spin-
coupled 8=2 centre, which can be best interpreted as arising from
high-spin ferric haem a3 (8=5/2) antiferromagneticaHy coupled
to cupric CUB (5=1 /2), yielding a binu>clear center of spin
S=2(Tweedle et at 1978).
III. Ligands of cytochrome oxidase
Cytochrome a is a hexacoordinated haem in which both
axial positions are occupied by histidines, so it does not react
with exogenous ligands. On the other hand , cytochrome a 3 is a
pentacoordinated haem with only one histidine as its axial ligand,
so it can react with various exogenous Iigands(Saraste 1990).
Oxidized enzyme in the 'resting'state as isolated is
conspicuously unreactive with cyanide, which reacts readily
with cytochrome 83 under turnover conditions orin partially
reduced enzyme(Nicholls and Chance 1974, Erecinska and Wilson
1978). That has led to the suggestion that the sixth axial position
of haem a3 in resting enzyme is occupied by a endogenous ligand,
such as a Jl-OXO bridge(Reed and Landrum 1979), or a sulfur atom
from a nearby aminoacid(Crinson 1991). Reductants will bre<ak
this ligation and thus lead to higher reactivity with exogenous
ligands including cyanide .
The fact that haem a3 but not haem a binds ligands in both
the ferrous and ferric forms has been extensively used to
evaluate the individual sp;ectra of the two haems(Wikstrom etal
1981). Among these ligands , cyanide is the most studied species.
Cyanide is a very effective inhibitor ofcytochromec oxidase. A
stoichiometric amount of cyanide is sufficient to inhibit the
enzyme completely(Nichollsand Hilde'brandt 1978a). Initially
Nicholls and Hildebrandt (1978b) concluded that the binding of a
single HCNmolecule prevented the reduction of both 83 and CUB.
But later this conclusion was revised(NichoHsand Chanady 1982).
21
Excess reductant permits the introduction of three reducing 22
equivalents into the cyanocytochrome aa3, Le.cytochrome S, .CuA
and CUB can all be reduced in the presence of cyanide.
MCD.·"spectroscopy (Babcock etal 1976) reveals a low spin
ferricytochrome 83 -HeN complex , but no f,ow spin EPR signal
corresponding to this complex is generated in the 'resting'
enzyme. However, a low spin cyanide complex signal is detected
in the presence of reducingequivalents(Shaw et at 1978).
This is explained by magnetic susceptibility
studies(Tweedle etal 1978). When cyanide j,sadded to the
oxidized enzyme, a binuclear complex , presumably ferric haem
8S-HCN(S=1/2)-cupricCu8(S=112) ,is forme>d ,with coupling
between low spin-iron and copper. EPR cannot detect this
complex, but MCD can still detect it.
The cyanide induced high to low spin change can also be
monitored spectrophotometrically(Nicholls at al 1976), as
evidenced by a red shift of theSoret peak upon adding cyanide.
The binding of cyanide with oxidized enzyme is very slow, but the
values of the rate constants vary considerably.
The problem of heterogeneity in the isolated enzyme has
long been a source of discussion(HartzeHetal 1988). Moody et al
(1991) claimed that in their enzyme preparation , there j,g a 'slow'
subpopulation in which the haem 83 is in the high spin form, and
two 'fast' subpopulations in which some hae·m as is in the low
spin form. The pH used in the preparation has quite a significant
influence. Moody et al(1991) argued that the 'fast' and 'slow'
forms of oxidase are equivalent to the late 'pulsed' and 'resting'
forms of oxidase. If this is correct, the rate constants- obtained 2 3
by Van Buuren at al (1972), Brittain and Greenwood(1976) and
Jones et al (1984) were characteristic of mixed species of the
enzyme. Since these authors did· not discuss in detail the problem
of heterogeneity and the contributions of 'fast' form to their
'resting' preparations , and 'peroxy' form to their 'oxyg'enated' or
'pulsed' preparations, Mitchell et al (1992) may ,be correct in
suggesting that the earlier enzyme preparations were mixtures of
the 'slow'(resting)'" the 'fast'('pulsed') and the 'peroxy' forms.
Nicholls et al (1976) showed that although the rate of
cyanide bindi.ng to fully reduced enzyme was more rapid than to
fully oxidized species, the rate of onset of inhib'ition under
turnover conditions was at least an order of magnitude greater
still. Jones et al(1984) proposed that a transient 2 or' 3-electron-
reduced form of the enzyme during turnover was responsible for
the observed extremely rapid binding. Mitchell at al (1992)
examined the rates of binding to the fully oxidized(O), two-
electron-reduced peroxy(P) and the three-electron-reduced oxy-
ferryl(F) forms of the enzyme, and concluded that none o·f these
states is responsible for the extremely rapid cyanide binding
during turnover. On the other hand, they detected a very small
fraction of one-electron-reduced (E state) oxidase within the
'fast' oxidized enzyme they prepared according to the method of
Moody et al (1991) . This small 'E" fraction has a rate constant for
cyanide binding in excess of 104 M-1 s-1 . It is concluded· by
these authors to be the species responsible for the rapid binding
of cyanide during turnover. The Estate , according to them, is not
oxidizable by oxygen, but can be slowly oxidized by ferricyanide. 24
The difference spectrum following incubation with ferricyanide
suggested that the electron in theE state is free to equilibrate
between the redox centers.
The binding of ferricytochrome c (or pOly-L-lysine) was
reported to induce a globalprotain conformational change that
increases the HCNbinding rate(Musatov and Konstantinov 1988).
But Mitchell at al (1992) found that the cytochrome c
stimulation of cyanide binding is most significant at
intermediate ionic strengths, though the binding of cytochrome c
to cytochrome oxidase is known to be electrostatic in nature. So
the latter propose that the mediation of electron transfer from
one-electron-reduced , cyanide ... liganded enzyme to the free
ferric oxidase by cytochromie c or ,pofy-L... lysine., rather than a
global protein conformational change , is responsible for the
stimulation.
The final word hasnotbeensaj'dyet as to which s:pecies is
responsible for the extreme,ly rapid inhibition :by cyanide during
turnover. Dioxygen activation and reduction in cytochrome c
oxidase is a complicated process which can involve as many as 11
transient states of the enzyme{Babcock and Wikstrom 1992).
Intra·centreelectron transfer means that several species can
share the same redox status. Even if we suppose all the species
that have been tested are truly involved in this oxidoreduction
cycle, there are still too many species left untested. Some
transient species might be so thermodynamically unstable that
their lifetime is very short, making themdi'fficuft to study. For
example, Shaw at al(1978) detected by EPR a high spin ferric 25
haem a3 which is highly reactive with ligands such sulphide,
cyanide and azide when generated by anaerobic oxidation of the
reduced enzyme with ferricyanide or porphyrexide. The lifetime
of this form is no longer than a few seconds.
I conclude that the higher reactivity with ligands of the
enzyme in turnover conditions does not imply that either the
'pulsed' or the 'oxygenated' form is ·of catalytic significance.
Azide reacts comparatively quickly with the oxidized
enzyme in contrast to cyanide(Nicholls and Chance 1974). But its
spectral effect upon the enzyme is complex(NichoHs at al 1976).
At a low concentration « 1mM), the spectrum shows a slight blue
shift. At higher levels (> 20mM), the Soret peak is shifted
towards the red. Since azide is the one Ugand which gives rise to
both high-and low-spin complexes with other haem
proteins(NichoHs 1976), it might be that at low concentration ,
azide causes a low to high spin shift of haem 83 , while at high
concentration , it has the opposite effect. Neither effect is as
marked as those produced by cyanide and fo'rmate(formate shifts
the Sorst peak to the blue (Nicholls 1976)),and in neither case is
any EPR-detectablelow spin or high-spin haem species form·ed
(Wilson and Leigh 1972). In partially reduced states of the
enzyme , EPR identifies a signal indicative of a low spin ferric
haem a3 to which azide is bound. Failure to detect an EPR s.ignal
in the 'resting' enzyme-azide complex may be due to a similar
cause to that with cyanide. A ferric 83·azide(S=1/2)- cupric
CUB(S=1/2) species may be form,ed with weak ferromagnetic or
antif~.rrQrrlagnetic coupling between low-spin iron and copper. 26
Nicholls and Hildebrandt(1978a) pointed out that while the
reduction of cytochrome a in the presence of azide under aerobic
steady state conditions is almost instantaneous, the high to low
spin shift of cytochrome a 3 , which is characterized by a red
shift of the high spin ferric peak in the Soret region, is relatively
slow. This transition correlates with a 605nm(ferrous) ex peak
shift towards the blue of a few nanometers during the steady
state. The <X peak of fully reduced enzyme in the presence of azide
remains at 605nm. The ex peak shift does not occur with cyanide,
even though , like azide , it gives a low spin(red-shifted) Soret
peak. After studying similar effects caused by sulphide and alkyl
sulphides, Nicholls and Hildebrandt(1978a) concluded that the ex
peak shift requires both (i) a low-spin cytochrome a 3 (ii) a
somewhat lipophilic ligand to haem a3. This phenomenon is an
important indication of the presence of haem / haem interaction
in the enzyme.
Sulphide reacts readily with oxidized cytochrome oxidase ,
yielding an optical change similar to that induced by cyanide
(Nicholls et al 1976), indicative a high to low spin transition of
ferric as, but the red shift of the Soret peak is more marked with
increased absorption at 445nm . A signal typical of low spin
ferric haem-sulphide compounds is detected by EPR in the
oxidized enzyme-sulphide complex(Wilson et al 1976).
Some phenomena , such as the high reactivity with oxidized
enzyme , the increase of absorption at 445nm, and the detection
of low spin EPR signals in the absence of other reducing agents,
can be readily explained by the partial reduction of the enzyme 2 7
by sulphide .
Formate induces a blue shift of the Soret peak(Nicholis
1976), indicating a high spin ferric haem a3-formate complex.
This was confirmed by an EPR study( abcock at al 1976). In
contrast to resting enzyme , cyan.ide- liganded or azide-liganded
enzyme, formate apparently keeps haem a3 in a high spin state
whether haem a is reduced or not{ Nicholls 1976). Competitive
binding was found between the formate and azide pair (Nicholls
1975), and the form·ate and cyanide .pair (Nicholls 1976).
Moody etal (1991) report that incubation of their 'fast'
oxidase with formate produces a form of the enzyme with
spectral and kinetic properties almost identical to those of
'slow' oxidase .These include the Soretpeak position, the slow
binding with cyanide and the lag in intramolecular electron
transfer. These authors suggested that formate may mimic a
binuclear center ligand which is present in the 'slow' form of
cytochrome oxidase. SchoonoverandPalmer(1991) also reported
that the 'g=12' signal , which is characteristic of high-spin haem
a3 in 'slow' oxidase, reappears after ,adding formate to 'fast'
oxidase. Although formate gives no spectroscopic sign of haem-
haem interaction , like cyanide it does show kinetic evidence of
such interactions(Nicholis 1976). Its affinity for the ferric high-
spina3 declines as haem a becomes more reduced, while the
affinity of cyanide for th'e ferric low-spina3 increases as haem
a becomes more reduced. So the redox state of haem a can
influence the affinity of formate and cyanide for fe,tric haem a3.
IV. lonophores
lono.phoresare Jipid-solublemolecufes that greatly
decrease the electrical resistance of lipid bilayer membrane
(Cramer and Knaff 1991). They can be classified as (i) mobile
carriers such as nigericin, FCCPand valinomycin whose activity
is frozen out at temperatures be·low the membrane lipid phase
transition due to their mobile nature (ii) channels such as
gramicidin whose activity is relatively insensitive to
temperature in membranes with a phase transition.
Valinomycin {s·ee Fig. 3 for its molecular structure) is one
of a group of antibiotics produced by Streptomyces . It contains
three repeating units of (L-lactate)-(L-valine)-(D-
hydroxyisovalerate}-(D-valine). ThedehydratedK+ ion is
coordinated precisely and specifically (the cation specificity is
Rb+>K+»Na+>Li+) to carbonyl groups in the hydrophilic interior of
the macrocycle,whose exterior is nonpolar and thereby soluble in
the membrane bilay~r. Because of itsK+ carrying ability ,
valinomycin dissipates the membrane potential d'l'in the
presence of K+. It has been axtensivelyused in mitochondrial and
reconstituted systems to investigate the effe·ctof a membrane
potential Ll'l' upon the activity of the respiratory chain.
Mitchell(1966b) proposed that cytochrome oxidase
generates a electrochemical proton gradient L.\JlH+by catalysing
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Fig. 3. (a) Structural formula of valinomycin 2 9
Adopted from Fig. 3.328 ( Cramer and Knaff 1991).
(b) conformational change of valinomycin upon
binding of potassium ion
The six carbonyl oxygen atoms in valinomycin are in one plane
when valinomycin is dispersed in polar solvents(Ovchinnikov
1974) in the absence of K+. In the presence of K+, the six carbonyl
oxygen atoms coordinate with a K+ and undergo conformational
change, resulting a octahedral shape.
e- transfer from ferrous cytochrome c on the C side of the 3 0
membrane andH+ transfer from theM side to the haem as/CuB
center, where electrons and protons were consumed in the
reduction of dioxygen to water. This is thermodynamically
equivalent to translocation of one H+ from theM side to the C
side per transferred e- ,even though no H+ ions are released on
the latter side(Wikstrom etal 1981).
Later it was found that cytochrome coxidase catalyses
true H+ translocation with uptake of 2H+/e"'on theM side ,
release of 1 H+/e- on the C side of the membrane and consumption
of 1 H+ in the reduction of 02 (Wikstrom 1977, Proteau et at
1983). The H+pumping activity , Le. the acidification of the
mediumatter a ferrous cytochrome cpulse, cannot ,be seen in the
absence of valinomycin. The reason seems to be that as aK+
carrier, valinomycin markedly increases the K+ permeability over
the H+permeability to the membrane. But recently Steverding
and Kadenbach(1989) reported that valinomycin not only acts as
a ionophore, but also binds cytochrome oxidase tightly with a
stoichiometry of 1:1. This binding has both spectral and kinetic
consequences. The difference spectrum. shows that valinomycin
induces a red shift of the Soret peak of the oxidizedenzyme,an
effect which is superficially similar to that achieved by adding
cyanide to the enzyme or pulsing the enzyme. The same spectral
change was also observed using isolated cytochrome oxidase
from Paracoccus denitrificans, which contains only subunits
andll( a third subunit was probably lost during purification).
Since subunits I and II from Paracoccus den itrifica ns are
analogous to subunits I and II from beef heart enzyme, the 3 1
authors suggested that valinomycin binds to one of the two
catalytic subunits of cytochrome oxidase.
Steverding and Kadenbach(1989) also found that the
stoichiometry of H+ pumped le- transferred reached a maximum
in cytochrome oxidase vesicles when the stoichiometry of
valinomycin : cytochrome oxidase reached 1 . In the absence of
valinomycin, only an alkalinization of the medium was observed,
due to rapid proton uptake. They concluded that the translocation
of K+ ions occurs via the enzyme-bound ionophore. It was also
suggested that theH+pumpingactivity of the enzyme might
result from a change of catalytic properties of the reconstituted
cytochrome oxidase after binding of valinomycin.
This view was later supportedbya comparative study of
valinomycin andnonactin{Steverding and Kadenbach 1990}.
Nonactin, another K+ carrying ionophore , stimulated the passive
influx of H+ into the vesicles which didnot contain cytochrome
oxidase at a greater rate than valinomycin did whenHCI was
added to the medium containing vesicles , suggesting that it
might baa more powerful K+ carrier than valinomycin. The
spectral shift and stimulation of the respiration rate ·of the
reconstituted cytochrome oxidase inducadby ncnactin were
nevertheless lower than those induced by valinomycin. This
apparent contradiction was also explained by assuming that
besides being a K+ carrier, valinomycin binds the enzyme directly
and .modi'fies its catalytic activity.
Another comparative study was ,done using valinomycin and
the channel-forming ionophore gramicidin(Prochaska and Wilson 3 2
1991). At low concentrations, gramicidin achieved an almost
identical H+ le- stoichiometry to that of valinomycin when
ferrous cytochrome c was added to oxidase-containing
proteoliposomes; at a high concentration, however, only an
alkalinization was observed. Since the ion selectivity of
gramicidin channels is H+> K+ (Cramer and Knaff 1991) there is
some doubt as to which ion was translocated to dissipate the ~'I'
during these experiments. But Prochaska and Wilson (1991)
argued that as there are 106 more K+ ions than protons, K+
ions were dissipating the d'l' at low gramicidin concentrations
while at higher concentrations , H+ ions were also translocated .
Since no spectral shift was found with gramicidin even at a
high concentration,and the concentration required to stimulate
proton translocation is 40-70 fold less than with valinomycin,
Prochaska and Wi·lson (1991) suggested that gramicidin does not
bind the enzyme , or at least not in the same fashion. As it
achieves an almost equal H+ 1e- ratio to that induced by
valinomycin, this suggests that cytochrome oxidase is truly a
redox-associated proton pump with the previously determined
H+/e- ratio of one.
A similar valinomycin-induced red shift in the oxidized
difference spectrum is also observed in phospholipid vesicles
containing subunit III-deficient cytochrome Qxidase(Prochaska
and Wilson 1991), further supporting the idea that valinomycin
binds with either subunit I or II as suggested by Steverding and
Kadenbach(1989).
V. Local anesthetics
Local anesthetics such as lidocaine, tetracaine and
dibucaine are used for anesthesia as well as in the treatment of
cardiac arrhythmias(MacDonald and Wann 1978). They depress
nerve action and cardiac signal conduction probably by blocking
ion (Na+, K+ and Ca2+) channels in the membrane. Their effects
are not limited to nerves, since they also affect a variety of
other systems, including the respiratory chain in mitochondria
(Chazotte and Vanderkooi 1981). Among these anesthetics ,
dibucaine is one of the most potent, whether in depressing nerve
actions(Singer 1980) or inhibiting the respiratory chain(Chazotte
and Vanderkooi 1981).
Altogether, four different kinds of local anesthetic effects
have been suggested in the literature:
(1) interaction with lipid bilayers (Eftink et al 1985);
(2) interaction with lipid molecules intimately associated with
the protein (Chazotte and Vanderkooi 1981);
(3) direct interaction with the protein without mediation of lipid
(Chazotte et al 1982);
(4) action as an uncoupler(Grouselle et al 1990).
Chazo·tte and Vanderkooi (1981) found that local
anesthetics inhibit aU segments of the respiratory chain in
mitochondria, with NADHdehydrogenase(Complex I) being the
most sensitive , and cytochrome c oxidase (Complex IV) the
least sensitive region. They also found that the 50% inhibitory
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concentrations are inversely proportional to water solubility, 3 4
suggesting that hydrophobic interactions may be of importance in
determining the stren.gth of· interaction o-f the various agents
with the enzyme . Concentrations of agents required for
inhibitio-n are too low to cause a general perturbation of the lipid
bilayer, and inhibition by different anesthetics occurs in
different concentration ranges. This implies a degree of
specificity which cannot be accounted for in terms of lipid
bilayer perturbation. These authors concluded that local
anesthetics either interact directly with the protein or with the
lipid molecules intimately associated with the protein. It was
also found that the inhibitory potency increases with the
temperature.
The dibucaine - oytochrome c oxidase interaction was also
studied by thermal anal:ysis(Vanderkooi and Chazotte 1982).It
was found that inhibition by dibucaine increases with increase
of temperature. The authors suggested. that dibucaine inhibits the
enzyme activity by causing a reversible perturbation of protein
conform·ation whose magnitude is muchsmaHer than that which
accompanies thermal denaturation.
Apart from the inhibitory effect" local anesthetics have
also been reported to uncouple oxidative phosphorylation in
isolated mitochondria (Dabadieet at 1987). Using a fluorescent
dye, Grouselle et al (1990) demonstrated that local anesthetics ,
such as dibucaine, can reach mitochondria when applied to a cell
culture medium . This process depends on their lipid-solubility
and can be enhanced by the presence of a lipophilic anion such as
TPB-. Local anesthetics have the same effects on mitochondria 35
inside the cells as on isolated mitochondria, i. e. they can
decrease, and probably even collapse', the mitochondrial
transmembrane potential. These effects of local anesthetics are
reversible.
Singer(1980) studied the effects of four cationic local
anesthetics on isolated cytochrome C oxid>ase. He found that
benzocaine, the one uncharged anesthetic, had no detectable
effect on enzy'me function , while other th,reespecies causa a
mixed type of inhibition, with the relative order of potency being
dibucaine>tetracains>procaine.He suggested an electrostatic
interaction ,but also pointed out that since procaine, dibucaine
and tetracaine have similar pK values, inhibitory potency cannot
be explained by such a'n electrostaticinteractionaJone.
Noticing that the inhibitory constants (Ki values) are very
similar to the anesthetic concentrations required to double the
width of the endothermic transition of
dipalmitoylphosphatidylcholineliposomes, Singer(1980)
proposed that both electrostatic and hydrophobic interactions
occur, with the charged portion o,f the anesthetic molecule
competing with the cytochromec f.or binding while hydrophobic
interactions between the anesthetic and oxidase-associated
phospholipids form non-productive substrate-enzyme complexes.
Singer(1982) found that at pH 7.4 dLbucaine behaved as an
uncompetitive inhibitor of the isolated enzyme, white at pH 6.0
the inhibition pattern became mixed in type. Positively charged
dibucaine may act predominantly by competing with cytochrome c 3 6
while the uncharged species interacts with the oxidase boundary
lipid to form anon-productive complex.
The effect of dibucaine on cytochrome oxidase
proteoliposomes was similar to that with isolated enzyme,but
less marked. This 'protective' influence of the b'ulk bilayer might
represent a dilution effect, i.e. binding of some of the local
anesthetic by the bilayers.
In a follow up study , Singer(1983) showed that local
anesthetics such as dibucaine and tetracaine had a m'uch greater
inhibitory effect on the stimulated (ionophore-treated)than on
the unstimulated proteoliposome enzyme. The inhibition pattern
of stimulated oxidase proteoliposomes is non-competitive with
respect to cytochrome c concentration. Pretreating
proteoliposomes with local anesthetics completely prevented the
stimulating effectsofionophores,such as valinomycin+FCCP.
Singer(1983) suggested that this was due to the interaction
between local anesthetics and the phosphoUpidcomponent of the
enzyme, which results in reduced internal electron transfer and
dissociation of the oxidase from the regulatory role of the pH
gradient.
Casanovas etal (1983) investigated the effects of eight
species of local anesthetics on isolated cytochrome c oxidase.
The inhibition varied from competitiv,e through mixed to a non-
competitive type. The patterns dapendedon anesthetic
concentrations. These authors concluded that reagents presenting
a strong anesthetic activity and existing in an ionized state bind
electrostatically to the enzyme at the cytochrome c binding 3 7
site, or to a site nearby . They also observed a linear correlation
between enzyme affinity and the octanol-water partition
coefficient of the anesthetics. So hydrophobic interactions are
also involved , and the interaction between enzyme and weakly
ionized molecules may be mainly hydrophobic in nature. These
conclusions are however weakened by the existence of quite a
few exceptions.
A different model was offered by the same group(Casanovas
at al 1985)in a study using the same local anesthetics . Here it
was proposed that the binding sita of local anesthetics is the
phospholipids attached to cytochromecoxidase . Strongly
ionized molecules can ·bind to a. peripheral site of the lipid phase
surrounding the protein and therefore modulate the enzyme
activity, resulting in mixed arnon-competitive type of
inhibition. This inhibition is relatively weak and may be
electrostatic in nature. Weakly ionized and lipophilic molecules
can compete with cytochrome c for binding at the active site
located closer to the lipid hydrophobic phase. This inhibition is
relatively strong and mayinvorve both electrostatic and
hydrophobic interactions.
Stringer and Harmon(1990) found that upon adding the
artifici·al electron donors ascorbate an·d TMPD to intact
mitochondria in the presence of dibucaine , the604nm peak was
nearly fully formed, but the 445nm peak only developed half of
the height of that in the absence of dibucaine. Since 80-90°/0 of
the absorbance of reduced oxidase at 604nm is due to ferrous
cytochrome a, and the rest to a3, while both cytochromes absorb 3 8
equally at 445nm (Yonetani 1960), it was concluded that
dibucaine inhibited electron transfer between the two
cytochromes, allowing reduction of cytochrome a but not of as .
The midpotentials of cytochromes c, a and as are not affected
by dibucaine. Dibucaine does not alter the absorbance maxima of
cytochrome a and a3.. On the other hand, the reduction of CUA
was hampered by dibucaine. So Stringer and Harmon (1990)
propose that the attacking site of dibucaine was located neither
on cytochrome a nor on cytochrome as, but on CUA.
Neither valinomycin nor dibucaine is a conventional oxidase
ligand. Both are large molecules with multiple effects and no
exact binding sites have been determined. In this thesis, the
following questions are addressed: (i) what is the relationship
between the dual role of valinomycin as enzyme ligand and as
ionophore? (ii) do the results obtained by Steverding and
Kadenbach (1990) demonstrate a relation between ligand binding
and charge separation in the oxidase? (iii) what are the
relationships between the roles of dibucaine as enzyme inhibitor
and as membrane-perturbing agent? and (iv) do the results of
Stringer and Harmon (1990) demonstrate a unique relation
between dibucaine binding and electron transfer in the oxidase?
The work described uses oxygen electrode, spectrophotometric,
and fluorimetric techniques to study effects of valinomycin and
dibucaine upon the enzyme in order to understand better the
relationships between their roles as protein ligands and enzyme
inhibitors and as membrane perturbantsand ionophores.
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SDH
Sigma
Sigma
Sigma
Sigma
Sigma
Sigma
Sigma
Sigma
Supplier
Fisher Scientific
Res.Organ.
Fisher Scientific
Sigma
Calbiochem.
SOH
SOH
LIST OF REAGENTS:
Reagent
Acetic acid (1 N solution)
Ammonium sulphate
Antimycin A(from Streptomyces kitazawaensis,
crystalline)
Ascorbate (L-ascorbic acid, sodium salt)
Asolectin (TypeIV-S, phosphatidylchoHne)
Cata'iase (EC 1.11 .1 .6) from Bovin,e liver
Cholate (Cholie acid, sodium salt )
Cytochromec (Horse heart, Type VI)
Dibucaine hydrochloride
EDTA (Ethylenediamine tetraacetic acid,disodium salt)
FCC P(p -trifluoromethoxycarbonylcyanide
phenylhydrazone) Dr .P .Heytler
(Dupont Chern.)
D-Glucose SOH
Glucose Qxidase(EC 1.1.3.4. )from Aspergillus niger Type X Sigma
HEPES(4-(2-hydroxyethyl)piperazin'eethanesulphonic
acid)
Hydrochloric acid
Lauryl (n-dodecyl-b-D) maltoside
Nigericin
Potassium cyanide
Potassium dihydrogenorthophosphate
Potassium ferricyanide
di-Potassiumhydrogenorthophosphata
Potassiumhydroxide(1N solution)
Potassium sulphate
Sephadex G-25{Bead size 50-150JlM)
Sodium borate
Sodium dithionite
Sodium formate
Sodium hydroxide
Sodium nitrite
Sodiumphosphate.Monobasic
Sodium phos.phate. Dibasic
Succinic acid (disodium salt)
TMPD(N,N,N,' N,'-tetramethyl-p-phenylenediamine.
Dihydrochloride salt)
Tween-80
Valinomycin
Fisher Scientific
SOH
Fisher Scientific
SOH
Sigma
J.T.Baker
SOH
SDH
Fisher Scientific
SDH
Sigma
S.igma
Sigma
Sigma
Sigma
Sigma
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* All reagents were of Analar™ grade or equivalent.
Purification of beef heart cytochrome c oxidase and
subm itochondrial particles
The enzyme preparation used throughout these studies was
beef heart mitochondrial cytochrome c oxidase. The enzyme was
purified according to the method of Kuboyama at at (1972). After
connective and fat tissue has been removed, the beef heart is
thoroughly min,ced and then washed several times in 5 mM sodium
phosphate, pH 7.4 . Submitochondrial particles are prepared from 4 1
the washed mince according to the method described by Brodie
and Nicholls (1970). The enzyme was isolated from these
particles by differential detergent solubilization, initially in
cholate and finally in Tween-BO, and repeated ammonium sulphate
fractionation. Tween-80 was used instead of the Emasol used by
Kuboyama et al(1972) . The final enzyme preparation was stored
in 100mM sodium phosphate, pH7.4 , 0.25% Tween-80 at -70oe.
The haem a lprotein ratio of submitochondrial particles is
1.1 )lmoles haem a Igram of protein. The haem a lprotein ratios
of the purified enzyme preparations used were 8.5-9.0 )lmoles
haem a Igram of protein. The concentration of protein was
determined using the Biuret method (Gornall at al 1949). The
concentration of cytochrome oxidase(two haams: a and a3 )was
determined using an extinction coefficient of 27mM-1 cm-1 for
reduced minus oxidized enzyme at 605-630nm(Nicholls 1978) .
The concentration of the stock purified enzyme was
between 400 and 700 JlM. The maximal turnover numbers were
470-580 )lM e-JlMaas -1 sec-1 in 50mM potassium phosphate, pH
7.4 at 30a C.
Preparation of pulsed cytochrome oxidase.
Pulsed cytochrome oxidase was prepared according to the
method described by Crinson and Nicholls (1992). Pulsed ,
cytochrome oxidase is 'resting' oxidase which has been fully
reduced and then exposed to oxygen. Sephadex G-25 beads were
swollen by overnight stirring in excess 50mM potassium
phosphate, pH 7.4 (30ml / 9 Sephadex G-25). The swollen beads 42
were then poured into a glass column to form a 10cm x 1.5cm
Sephadex G-25 gel filtration column. Purified oxidase in 50mM
potassium phosphate , pH 7.4, 0.0150/0 lauryl maltoside was
reduced by the addition of 1.0mg/ml sodium dithionite and left on
ice for 30 min to ensure complete reduction of the oxidase.
Catalase (2000units/ml; one enzyme unit will decompose 1Jlmole
H202 per min at pH 7.0 at 25 °C ) was added to the mixture to
ensure that any hydrogen peroxide was rapidly removed . The fully
reduced enzyme was then loaded onto the column, which had been
equilibrated with 50mM potassium phosphate , pH 7.4, 0.015%
lauryl maltoside. This same air-saturated buffer medium was
used to wash the enzyme through the column , the eluted enzyme
being in the pulsed form as determined spectroscopically. The
initial product has a Soret peak at 426nm and is unstable, as
evidenced by the gradual blue shift of the Soret peak to 422nm,
but this 422nm species is stable for at least 3 hours.
Preparation of cyanide-liganded and formate-liganded
cytochrome oxidase .
Cyanide-liganded and formate-liganded cytochrome oxidase
were formed by incubating 0.12 mM oxidase with 40 mM HCOONa
or 2mM KCN respectively in 50 mM potassium phosphate , pH 7.4
containing 0.015% lauryl maltoside. The mixtures were incubated
at 4°C for 48 hours and then diluted to the desired concentrations
in 50 mM potassium phosphate, pH 7.4 , 0.0150/0 lauryl maltoside
for use in the assays.
Preparation of vesicles containing cytochrome oxidase 43
Sonicated vesicles containing cytochrome oxidase were
prepared according to the method of Proteau et al (1983). 250 mg
L-a-phosphatidyl choline(L-a-lecithin from soybean, Sigma
P-3644) were dispersed in 5.0 ml 50 mM potassium phosphate,
pH7.4 using a whirlimixer. To this was added 5JlM enzyme.
This mixture was sonicated using a Heat Systems Sonicator
3/4 inch probe, 30 % duty cycle, power 3, for 9 minutes. The
sample was kept on ice and under a stream of nitrogen during
sonication. The sonicated mixture was centrifuged at 13,000
rpm for 10 minutes , using the 88-34 rotor in the Sorvap RC-5 or
the 870 rotor in the IEC B-20A centrifuge(temp. range 2-7°C). The
clear supernatant from this spin was taken as the sonicated
vesicles. Using the method described by Nicholls et al (1980), it
was determined that total cytochrome oxidase concentration in
the vesicles was between 3.6JlM and 4.1 JlM , and 49% to 500/0 of
the cytochrome c reaction sites were on the outside of the
vesicle membrane. The respiratory control ratio was between 5
and 6.5.
Polarography
Turnover studies were carried out by measuring the oxygen
consumption polarographically with a Clark type oxygen
electrode(Yellow Springs Instruments) connected to a polarizing
box (Brock University electronics shop). The signal was measured
on either a Radiometer Ree 61 Servograph or a Cole-Parmer
Versagraph chart recorder. The reaction vessel was a 4.3 ml
chamber which was magnetically stirred and thermostatically 44
controlled by a water jacket. When the electrode was placed in
the reaction vessel, air was excluded from the chamber, leaving
only a small opening for injection of substrates using a Hamilton
syringe.
Spectrophotometry
I. Spectra of cytochrome c oxidase derivatives
(a) titrations with valinomycin and dibucaine
Desired concentrations of cytochrome oxidase were added
to a 1cm-lightpath , 1ml-volume quartz cuvette. Aliquots of
valinomycin or dibucaine were added and spectral changes were
monitored. Spectra were obtained using a Beckman DU-7
spectrophotometer and stored for later analysis, using a linked
Apple 11+ or Apple IIGS computer via a domestic data acquisition
programme(Chanady et al 1985). Appearance of low spin
cytochrome as was followed using the 433-413nm wavelength
pair. For valinomycin, the apparent dissociation constant,
Kd(app), and the extinction coefficient ~EmM433-413nm were
obtained by fitting the data to a user-defined 'Binding' function in
the Multifit™ v.2.00 (Day Computing , Inc., Milton, Cambridge, UK )
package on a Macintosh Classic 68000 device . The derivation of
this 'Binding' function is as follows:
Kd(app) = [e]*[L]/[eL] Eq. 2
Where [e] is the free enzyme concentration, [L] is the free ligand
concentration, [ell is the enzyme-ligand complex concentration.
Since [e]t=[e]+[el], [l]t = [l]+[eL] (where felt is the total
enzyme concentration, [l]t is the total ligand concentration), Eq. 2 45
can be rewritten as
Kd(app) = [e]t-[el])*([l]t-[el])/[el] Eq. 3
EmM = ~A/[el] Eq. 4
Where ~A is the spectral change induced by the ligand, Em M is
extinction coefficient of this spectral change.
Substituting [ell with ~A/EmM according to Eq. 4, Eq. 3 can
be again rearranged as :
~A=EmM*{([e]t+ [L]t+ Kd)-SORT(SOR([a]t+[l]t+Kd)-4*[e]t*[L]t) }/2
--------Eq. 5
Where SORT is the square root of the operand . SOR is the square
of the operand. Eq. 5 is the 'Binding' function.
For dibucaine, Kd(app) and EmM433-413nm ware obtained both
by fitting data to Eq. 5 and by using a double reciprocal plot , and
the results were compared. It is not possible to determine
Kd (app) and EmM433-413nm for valinomycin by a simple double
reciprocal plot since the valinomycin concentration used was
comparable to the enzyme concentration used.
(b) Dual wavelength spectrophotometric study of the
kinetics of valinomycin and dibucaine binding with
cytochrome oxidase
The kinetics of valinomycin binding with the resting enzyme
were followed by monitoring the spectral change at the 433-
413nm wavelength pair using an Aminco DW2 UV/Vis
spectrophotometer, in dual wavelength mode, linked to a Compaq
286 computer with an Olis™ data acquisition package. Different
concentrations of valinomycin were added to 4J.1M enzyme in a 46
1cm-lightpath , 3ml-volume quartz cuvette to start the reaction.
The apparent rate constants kappfor the binding were obtained by
fitting the trace to a appropriate function in the OIiS™ fitting
programme.
The kinetics of dibucaine binding with the resting enzyme
were studied by adding 1.5mM dibucaine to SJlM enzyme, then
monitoring the spectral change at the 433-413nm wavelength
pair using an Aminco DW2 UV/Vis spectrophotometer(in dual
wavelength mode), linked to a Compaq 286 computer with an
01 iS™ data acquisition package. A 1cm-lightpath, 1ml-volume
quartz cuvette was used. Dibucaine binding with the enzyme in
turnover conditions was studied by monitoring the steady state of
cytochrome craduction. Active enzyme concentrations during the
shifting cytochrome c steady states which accompa:ny dibucaine
binding were analysed by the method of Nicholls at al (1974),
. treating the acti.ve enzyme species as having a concentration
proportional to the function [c2+]o[c3 +]t/[c3+Jo[c2 +]t, where
[c2+]0/[c3 +]0 is the ratio of reduced to oxidized cytochrome c
immediately beforedibucai'ne( the enzyme inhibitor ) addition,
and [c2+Jt/[c3 +]t is the corresponding ratio at any subsequent
time.
II. Spectra of cytochrome c oxidase during turnover
(a) Steady state spectral scan.
The spectra of cytochrome C QXidaseduring turnover were
studied by a Beckman DU-7 spectrophotometer and stored for
later analysis, using ,a linked Appl.e 11+ or Apple IIGS computer via 4 7
a domestic data acquisition programme(Chanady at at 1985) .
Experiments were performed in a 1cm-lightpath , 1ml-volume
quartz cuvette. Reduction was initiated by add'ing suitable
concentrations of either ascorbate plus cytochrome c or
ascor,bate plus TMPD to an aerobic solution containing cytochrome
oxidase. The reduction of cytochrome a ,cytochrome a + a3 ,
and cytochrome c were foUowedby monitoring the absorbance
increase at the 605'nm band , 445nm band, and 550nm band
respectively. The reductionofCuA was studied by following the
absorbance decrease at the 830nm band. After anaerobiosis,
dithionite was added to secure the full reduction of the oxidase.
The experimental temperature was 30°C .
(b) Dual wavelength spectrophotometry
Steady-state studies of the enzyme in turnover were
performed in an Aminco DW2 UV/Vis sps'ctrophotometer, in dual
wavelength mode, linked to a Compaq 286 computer with anOlis™
data acquisition package. Experiments were performed in a 1cm-
lightpath , 1ml-volumequartz cuvette. Reduction was initiated
by adding suitable concentrations of s'ither ascorbate plus
cytochrome c or ascorbate plus TMPD to an aerobic solution
containing cytochrome oxidase . The reduction levels of
cytochrome a ,cytochrome a + 83, and cytochrome c were
followed using the wavelength pairs 605-630nm , 445-470nm and
550-540nm respectively. After anaerobiosis, dithionite was
added to secure the fuB reduction of the oxidase. The
experimental temperature was 30°C.
Fluorescence and phosphorescence spectrophotometry
I. Fluorescence and phosphorescence spectra
Fluorescence and phosphorescence spectra of resting
cytochrome oxidase and valinomycin-liganded oxidase were
obtained using a Perkin Elmer LS-50luminescence spectrometer
and stored, using a McCOMP 386 computer with the FLDM data
acquisition programme, for later analysis. A solution containing
0.2 JlM resting enzyme, 50mMpotassiumphosphate, pH 8.0 and
0.015% lauryl maltoside was added to a 1cm-lightpath, 3ml-
volume fluorescence cuvette. Where indicated, the "oxygen trap"
was composed of 80nM glucose oxidase, 20nM catatas'e and 0.05%
glucose. To minimize the quenching of phosphorescence by
oxygen, the buffer had been bubbled with pure argon for 20
minutes before takingph.osphorescence spectra and a layer of
mineral oil was put on the surface o·f the deoxygenated solution
to prevent it from contacting the atmosphere again. The spectra
of the valinomycin-liganded species were taken 40 minutes after
9JlM valino.mycin was added to the solution. The experimental
temperatu re was 14°C. The filter position was set at 'clear'. For
fluorescence spectra, the emission and ex-citation wavelengths
were 33·0nm and 290nm, and both the excitation and emission
slits were set at 5.0 nm for phosphorescence spectra, the
emission and excitation wavelengths were 445nm and 275nm ,
the gate time was 5.0ms, and the delay time is O.2ms. Both
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excitation and emission slits were set at 15 nm to increase the 4 9
signal, and the average of 10 scans was taken to produce the
final result.
II.Nitrite quenching of phosphorescence of cytochrome
oxidase± valinomycin.
Phosphorescence spectra were obtained as above. A
solution containing 7 JlM cytochrome oxidase or 7JlM cytochrome
oxidase plus 10 f.lM valinomycin, 50mM potassium phosphate,
pH8.0 and 0.015% lauryl maltoside was added to a 1cm-lightpath,
3ml-volume fluorescence cuvette . The buffer had been bubbled
with pure argon for 20 minutes to remove the oxygen before being
added to the cuvette, and a "oxygen trap" composed of 80nM
glucose oxidase , 20nM catalase and 0.050/0 glucose was also
included. As described above, mineral oil was put on the top of
the deoxygenated solution, and during subsequent measurements,
aliquots of sodium nitrite were added using a Hamilton syringe.
The phosphorescence emission spectra were measured using
either 260nm or 295nm as the excitation wavelength. The
excitation spectra were recorded using 460nm as the emission
wavelength . The gate time was 3.0 ms , and the delay time was
O.4ms. Both the excitation slit and emission slit were set at
15.0nm . The experimental temperature was 4°C.
RESULTS
Part I : Valinomycin-cytochrome oxidase interaction
A. Spectroscopic effects of valinomycin
In order to understand the spectroscopic effect of
valinomycin, control experiments were first carried out with
conventional ligands. These derivatives were prepared as
described in Methods and Materials.
Fig. 4A shows the Soret spectra of the resting enzyme, and
the formate-liganded, 'pulsed' and cyanide-liganded cytochrome
oxidase . The absorption maxima are located at 419nm, 416nm,
424nm and 427nm respectively. Fig. 48 presents the
corresponding difference spectra. Both 'pulsed' and cyanide-
liganded enzyme have a peak at 433nm and a trough at 413nm,
while the formate-liganded enzyme has a peak at 413nm and a
trough around 433nm, essentially the reverse of the 'pulsed'
enzyme spectrum. Addition of valinomycin to the resting enzyme
has a similar effect to that of cyanide. That is , it shifts the
Soret peak of the oxidase spectrum to the red, although the
amplitude of the valinomycin effect is less marked(Fig. 5) .
The time course of the development of the valinomycin
spectrum is shown in Fig. 6. The difference spectra also have a
peak around 433nm and a trough at 413nm, as with the cyanide-
liganded species. The development of this valinomycin-induced
spectral shift takes around 30 min. It can therefore be studied by
following the absorbance change at the wavelengths of the peak
and trough positions, Le. , 433nm and 413nm, where the effect is
at a maximum.
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Fig. 4A. Absolute spectra of high and low spin forms of 5 1
cytoc<hrome oxidase
The experiments were carried out in 50mMpotassium phosphate ,
pH 7.4 ,0.015% lauryl maltoside at 30°C, using the Du-7 Beckman
spectrophotometer. The enzyme concentration was 4JlM. The
pulsed enzyme spectrum was taken 45 minutes after the
preparation . Formate and cyanide concentrations were 40mM and
2mM respectively where indicated. The details of formation of
'pulsed I, formate-liganded and cyanide-liganded enzyme are
described in Methods.
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Fig. 48. Difference spectra of high and low spin forms of 5 2
cytoch.rome oxidase
The difference spectra were obtained from the absolute spectra
in Fig. 4A by subtracting the resting enzyme spectrum from the
spectra of other species. Experimental conditlons are as in Fig.
4A.
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Fig. 5 Spectra of the resting and valinomycin-liganded 5 3
enzyme.
Experiments were conducted in 50mM potassium phosphate ,
pH7.4, 0.015% lauryl maltoside at 30°C using the DU-7 Beckman
spectrophotometer. The enzyme concentration was 4JlM. 100J.!M
ferricyanide was added to the cuvette to keep the enzyme in its
oxidized form. The spectrum of the valinomycin-liganded species
was taken 30 mins after 4JlMvaiinomycin had been added to the
cuvette.
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Fig.6 Progressive appearance of valinomycin-oxidase 5 4
complex : Difference spectra(valinomycin-liganded minus
resting enzyme).
Experiments were conducted in 50mM potassium phosphate ,pH?.4,
0.0150/0 lauryl maltoside at 30°C using the DU-7 Beckman
spectrophotometer. The enzyme concentration was 4JlM. Spectra
were taken at 1Osee, 1min, 3min, 5min,1 Omin, 20mi,n and 30min
after 4JlM valinomycin had been added to 4JlM resting enzyme. The
spectrum of resting enzyme was subtracted from each
valinomycin spectrum.
A sample of enzyme was incubated with varying amounts of 5 5
valinomycin and the spectral change recorded after 15min. Fig. 7
plots the corresponding absorbance change as a function of
valinomycin concentration.
In Fig.7A, the results are shown for the reaction in 10mM
HEPES, while in Fig.78 the corresponding results in the presence
of 100mM K2S04 are seen. The effect of ionic strength upon the
valinomycin-induced spectral shift is rather limited. The
difference extinction coefficient (LiEmM433-413nm) has the same
value of probably 22mM-1 c m -1 at both high and low ionic
strengths. The data were fitted to an appropriate "Binding"
equation in Multifit™(please see Methods), and the results are
plotted as the solid lines in the two figures. The dissociation
constant, Kd , for high ionic strength is 2.5JlM , and that for low
ionic strength is 3.1JlM. If these parameters are used, the
resulting curves fit the data quite nicely.
The rate of valinomycin binding was followed in the DW-2
dual wavelength spectrophotometer. Fig. 8A shows the spectral
changes as a function of valinomycin concentration. The initial
rate Vo of the absorbance change at 433...413nm wavelength pair,
calculated as AA per minute, varies linearly with valinomycin
concentration. On the other hand, the apparent rate constant k,
with the dimension sec- 1 , is independent of valinomycin
concentration and reflects the half time for formation of the
ap.propriate fraction of bound enzyme in each case(Fig. 88) .
The linear relation between initial rate and valinomycin
Fig. 7
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Fig. 7 Effect of valinomycin concentration upon the 56
spectral shift of cytochrome oxidase at high & low ionic
strengths.
The experiments were performed in 10mM potassium HEPES, or
10mM potassium HEPES + 100mM K2S04 buffer, pH7.4 , 0.0150/0
lauryl maltoside at 30°C using the DU-7 Beckman
spectrophotometer . The oxidase concentration was 2.5 JlM .
Aliquots of valinomycin were added and spectral changes
recorded after 15 mins incubation.
The solid lines were obtained by fitting the data with a
"Binding" function(This function is defined as Eq. 5 in Methods).
The Multifit™ fitting programme for the Macintosh was used.
The extinction coefficients for high and low ionic strengths are
22.9 ± 4 mM- 1cm- 1 and 21.5 ± 2 mM- 1cm- 1 respectively. The
dissociation constant Kd for high ionic strength is 2.8 ±1.0JlM,
while that for low ionic strength is 3.1 ± 0.7JlM.
A. titration plot at high ionic strength(10mM potassium
HEPES + 100mM K2S04. )
B. titration plot at low ionic strength(10mM potassium
HEPES alone)
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Fig. BA. Kinetics of valinomycin binding to resting 57
cytochrome oxidase Time courses of valinomycin
binding followed at 433-413nm.
The experiments were carried out in 50 mM potassium phosphate ,
pH7.4 , 0.015°/0 lauryl maltoside at 30°C in a DW...2 Olis™ dual
wavelength spectrophotometer. 0 ... 3.33 JlM valinomycin were
added to 4.0 JlM enzyme in a 1cm... lightpath, 3ml ...volume quartz
cuvette to start the reaction as indicated on the trace. Ethanol
concentration was kept constant at 0.4 0/0. The results of a single
experiment are shown . Fitted kinetic values are given in Fig. 88.
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Fig. 88 Kinetics
cytochrome oxidase
kinetics.
Apparent rate constants kapp for binding were obtained as the
reciprocals of apparent halftimes t1/2 • The initial rate Va w a 5
obtained by fitting the curves in Fig. 8(A) with the "straight line"
function from the Olis™ fitting programme within two minutes
after adding valinomycin . Data are from the single experiment of
Fig. BA. Conditions as in the legend to Fig. BA.
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concentration indicates that the valinomycin-enzyme interaction 5 9
is a 2nd order reaction, which can be described by the following
equation(Mathews and van Holde 1990):
k1
E + V f-----;
k-1
EV Eq.6
Where E: enzyme
enzyme complex
V: valinomycin EV: valinomycin-
The rate of the formation of the valin,omycin-enzyme
complex can be described by the foHowingequation:
d([EV])/dt=k1 *[E]*[V]-k.. 1*[EV] Eq. 7
When t=O, the concentration of EV is insignificant, so the
contribution of the second item at the right of equation 7 can be
neglected:
d([EV])/dtlt=o = k1 *[E]*[V] Eq.8
The slope obtained from the relation between the initial
rate Vo and the valinomycin concentration in Fig. 88 is 3.2 tiA
min -1 m M-1 . Using the extinction coefficient Em = 22mM-1 c m- 1
obtained from Fig. 7 and an enzyme concentration [E]=4JlM, k1 can
be calculated according to Eq. Bas 600 M-1 s-1. As:

Parameters Fig.8
(Kinetics)
Table I
Fig.?
(Equilibrium)
kapp 0.0046s-1 #
0.0022s-1 * 0.0015-
0.0019 s-1**
2.5-3.1 JlM #
#Direct measurement
Table 1. Rate constants for valinomycin-cytochrome 6 1
oxidase interaction.
Values listed in the second column are those used for the fittings
in Fig. 88 . Values listed in the third column are those obtained
from the fittings in Fig. 7 . Experimental conditions are listed in
the legends to Figs. 8A and 7 respectively.
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Fig. ,9 Effect of cation composition upon the valinomycin- 6 2
induced spectral shift of cytochrome oxidase
The experiments were carried out in a DW-2 CBs dual wavelength
spectrophotometer at 30°C. The medium was 50 mM potassiu.m or
sodium phosphate , pH 7.4. It also contained O.015°k lauryl
maltoside . The enzyme concentration was 2.5 JlM and 3.3 JlM
valinomycin was added to a 1cm-lightpath, 3mt-volume quartz
cuvette to start the reaction as indicated on the trace.
Medium
potassium
phosphate
sodium
phosphate
Ratio
~Am(433­
413nm)*
0.036
0.014
2.5
Table 2
Initial rate
(L\A/min)**
4.2E-3
7.9E-4
5.0
* Maximal absorbance change(2.5J,!M enzyme)
** Rate of absorbance change(3.3JJ,M valinomycin)
Table 2. Comparative study of valinomycin-cytochrome 63
oxidase interaction in different media
The listed values are obtained from the single pair of
experiments shown in Fig. 9, using the Olis™ double exponential
fitting routine. The second column lists the final maximal
absorbance changes at the indiacted wavelengths. The third
column lists the initial rates of absorbance change. All conditions
are given in the legend to Fig. 9.
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Fig. 10. Effect of valinomycin upon steady state enzyme 64
activity.
The experiments were performed in 50mM potassium phosphate,
pH 7.4 , 0.0150/0 lauryl maltoside and 13JlM cyt. c at 30°C. 1.5JlM
cyt. aa3 was incubated at the desired valinomycin concentration
for 1.0 h before 10mM ascorbate was added to start the reaction.
The reduction of cytochrome c was monitored at the 550-540nm
wavelength pair, using the DW-2 dual wavelength
spectrophotometer. A 1cm-lightpath, 1 ml-volume quartz cuvette
was used to hold the reaction mixture. The figure shows the
results of a single experiment. Replicates give similar results
(steady state values differing by no more than ± SOlo).
Cytochrome c is reduced by ascorbate according to Eq. 10: 65
AH2 + 2c3+---~ A + c2+ + 2H+ Eq. 10a
v = kr[c3+][AH2] Eq. 10b
where AH and A are reduced and oxidized forms of ascorbate
respectively, v is the velocity, kr is the rate constant for
reduction.
Cytochrome c is reoxidized by cytochrome oxidase
according to Eq.11 (Minnaert 1961):
02
c2+ + ef---~c2+e --~ c3+e f---~ e + c3+ Eq.11 a
v=kO[c2+]e/(Km+[c]total)= 4[02]/tanaerobic Eq. 11 b
Where ko is the rate constant for oxidization of ferrous
cytochrome c by the oxidase, Km is the Michaelis constant for
cytochrome c and tanaerobic is the time taken for the solution to
become oxygen-free.
In Fig. 11 A, kr , the rate constant of reduction of
cytochrome c by ascorbate was calculated from Eq. 1Db and
plotted against valinomycin concentration. Valinomycin has little
effect on kr, indicating that the inhibition does not occur at this
step. The average value of kr under these conditions was 80M-1
s-1. On the other hand, ko , the rate constant for oxi,dization of
ferrous cytochrome c by the oxidase, decreases substantially
with an increase in valinomycin concentration (Fig. 11 B). But
even at a high valinomycin concentration, there is still some
Fig.11
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Fig .. 1 1.. Kinetic analysis of the effects of valinomycin 6 6
upon the ascorbate-cytochrome c-cytochrome a83-02
steady state.
A. Reduction of cytochrome c by ascorbate.
The second order reduction rate constants were calculated from
the steady state data of Fig. 10 according to the method described
on p.65 of the Results. The straight line is drawn for a constant
krvalue of 81M-1 s-1. Conditions are as in the legend of Fig.10.
Error bars are not shown (s~e Fig. 10 legend ).
B.. Enzymatic activity (turnover).
The turnover numberko is the oxidation rate constant calculated
according to the method described on p.6S of the Results . The
theoretical curve is drawn for a Kd of 1JlM and a residual activity
of 45%. Conditions are as in the legend of Fig. 10. Error bars are
not shown (see Fig. 10 legend ).
residual enzyme activity. The maximum percentage inhibition is 67
approximately 55%, and theKi, the valinomycin concentration
causing half of the maximum inhibition, is estimated as
1.0JlM(see fitted curve, Fig.11 B) .
The valinomycin effect upon electron transfer in the
absence of cytochrome c was investigated by following the
steady state reduction of cytochrome a by ascorbate plus TMPD
at 605-630nm (Fig. 12). A relatively low buffer concentration
(10mM potassium phosphate) was used to promote the reaction
velocity without adding too high a concentration of reductant. The
steady state reduction of cytochrome a increases from 23% in
the control condition to 280/0 in the presence of 10f.!M
valinomycin. The anaerobiosis time also increases when
valinomycin is present, indicating an inhibition of the intrinsic
enzyme activity in the absence of cytochrome c.
Valinomycin is both an ionophore, and, as shown above, an
inhibitor of cytochrome oxidase. It is therefore important to
understand the relationship between these two functions of
valinomycin. The respiration rate of cytochrome oxidase-
containing proteoliposomes was studied over a wide range of
valinomycin concentration (up to 8.5JlM,) ,using the 02 electrode
method(Fig. 13). When another ionophore , either FCCP or
ni'gericin, is present, less than O.1JlM valinomycin is enough to
stimulate fully the respiration of the proteoliposomes. As the
valinomycin concentration is increased, a partial inhibition of the
FCCP or nigericin-stimulated rate , giving a 20%decrease of the
maximal respiration rate, is obs'erve'd. Kj, the valinomycin
Fig. 12
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Fig. 12 Steady state reductionaf cytochrome a induced 6 8
by TMPD: action of valinomycin.
The experiments were conducted in 10mM potassium phosphate ,
pH 7.4, 0.0150/0 lauryl maltoside at 30°C. 3.1 JlM cytochrome aa3
was incubated in 10JlM valinomycin for 30 min before 10mM
ascorbate plus O.4mM TMPD were added to start the reaction. The
reduction of cytochrome a was monitored at 605-630nm
wavelength pair, using DW-2 dual wavelength spectrophotometer.
A 1cm-lightpath, 1ml-volume quartz cuvette was us·ed to hold the
reaction mixture.
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Fig. 13. Respiration rates of cytochrome oxidase- 69
containing proteoliposomes: influence of different
valinomycin concentrations in presence and absence of
FCCP and nigericin.
Polarographic experiments were carried out with sonicated COV
prepared as described in Methods, with lipid:protein ratio=25:1
and 49% cytochrome aa3 externally-facing. The reaction' medium
was 50mM potassium phosphate, pH 7.4, with 9 nM (total) aa3 ,
10 JlM cytochrome c , 1.0JlM FCCP and O.16JlM nigericin where
indicated. The valinomycin concentrations range from 0.0 to
8.5IJ.M. The experimental temperature was 30°C. The figure shows
the results ofa single set of experiments. Similar experiments
give essentially similar results.
concentration required to cause a half maximal effect ,is 7 0
estimated as 1.0JlM.
When valinomycin alone is present, the respiration rate
increases slightly with increasing concentrations of valinomycin
up to approximately 21J,M. The Kd for this effect, the valinomycin
concentration required to cause a half maximal increase, is about
O.2J.lM. It may be noted that the maximal activity in the absence
of either FCCP or nigericin is about 500/0 that in their presence
and 40% of the maximal activity at the lowest concentrations of
valinomycin.
C.Protein fluorescence and phosphorescence effects of
valinomycin-cytochrome oxidase interaction
Protein fluorescence and phosphorescence have proven to
be very useful as monitors of protein conformation(Lakowicz
1983, Papp and Vanderkooi 1989). Fig. 14A shows that the
fluorescence excitation spectrum of cytochrome oxidase has a
peak at 281 nm , which is close to the normal protein absorption
peak. After adding the "oxygen trap", a slight increase of intensity
can be seen, but the peak position does not change. Valinomycin
causes a slight quenching but does not change the peak position
either. The position of the emission spectrum peak(Fig.14B) is
located at 336nm when aa3 alone is present, but it moves to
338nm when the " oxygen trap" is added. The "oxygen trap" also
causes abroad intensity increase in the longer wavelength range
above 338nm, which is probably due to strong fluorescent
interference from flavin groups in glucose oxidase in the
Fig. 14(A)
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Fig.14A.Fluorescence excitatj·on spectra of cytochrome 7 1
oxidase ± valinomycin
Fluorescencespactra were obtained using a Perkin Elmer LS-50
luminescenc:e spectrometer and stored, using a McCOMP 386
computer with the FLDM data acquisition programme, for later
analysis. 0.2 JlM aas was added toa 1cm... lightpath, 3ml-volume
fluorescence cuvette containing 50m:M potassium phosphate, pH
8.0 and 0.0150/0 lauryl maltoside. Where indicated, the "oxygen
trap" was composed of80nM glucose oxidase,20nM catalase and
0.050/0 glucose. The spectra of the vaHnomycin-Uganded species
were taken 60 min after 9~lM valinomycin was added to the
solution. Theexperimentaf te'mperature was 14°C. Both the
excitation slit and the emission slit were 5.0nm. The filter
position is 'clear'. The Y axis unit is arbitrary. The emission
wavelength = 330nm.
Fig. 14(8)
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Fig.148 Fluorescence emission spectra of cytochrome 7 2
oxidase ± valinomycin
The excitation wavelength = 290nm. Other conditions were
identical as those of Fig. 14A.
"oxygen trap" ~ Valinomycin causes a slight quenching (8°/0) of the 7 3
intensity at the 33,8nm peak , and has very little effect in the
I(onger wavelength ra'nge.
Recently room temperature phosphorescence from
cytochrome oxidase has beenreported(Pappet ai, 1991) and
suggested to be a more selective probe of protein structure than
fluorescence. Fig.15A shows that phosphorescence excitation
spectra of aa3, aa3 +"oxygen trap", andas3 + "oxygen
trap"+valinomycin aU have apeak position at 275nm, so' that if
excited at 275nm, the emission should give the maximal
signal. The emission spectra (Fig.15B) show two peaks. The
smaller peak around 340nm is most probably due to a contribution
from fluorescence, since the fluorescence emission spectra also
have a .peak aroun·d this wavelength(seeFig. 148) . But the
intensity has dropped from 65(arbitrary unit) to 0.1, indicating
that the lifetime of this signal is very short. On the other hand,
the bigger peak around 447nm the true phosphorescence peak,
which has a longer lifetime. Adding the "oxygen trap" or
valinomycin causes a slight increase of the intensity of both
peaks,but the pe,ak positions are not affected.
In order to unders.tandbetter the valinomycin-induced
conformational change of the enzym>e ,NaN02 quenchJng behaviour
towards cytochrome oxidase in the absence and presence of
valinomycin was also investigated (Fig. 16). Some experim,ental
conditions were sHghtlychanged to optimize the phos'phorescence
signal. The aa3 concentration wias increased from O.2JlM to 71lM
to increase the signal, and the experimental temperature was
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Fig.1 5 A Phosphorescence excitation spectra of the 7 4
deoxygenated cytochrome oxidase ± valinomycin
Phosphorescancespectra were obtained using a Perkin Elmer LS-
50 luminescence spectrometer and , u.sing a McCOMP 386
computer with the FLDM dataacqu.isition programme, for later
analysis. 0.2 JlM aaa was added to a 1cm-lightpath, 3ml-volume
fluorescenc:e cuvette containing 50mMpotassium phosphate, pH
8.0 andO.015% lauryl maltoside. The buffer had been bubbled with
pure argon for 20 min to remove the oxygen before being added to
the cuvette, then a layer of mineral oil was put on the top of the
deoxygenated solution to prevent it from contacting the
atmos,phere. Where indicated, the "oxygen trap" was composed of
80nM glucose oxidase, 20nM catalase a'nd 0.05%glucose.. The
spectra of valinomycin-liganded species were taken 30 min after
9JlM valinomycin was added to the solution. The experimental
temperature was 14°C. Both the excitationsUt and emission slit
were 15.0nm. The V axis unit is arbitrary. Average of 10 scans
were taken in each case. The Gate time =5.0ms . Delay time =
O.2ms . The emission wavelength == 445nm.
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Fig.1 5 B Phosphorescence em n spectra of the 7 5
deoxygenated cytochrome oxidase ± val.inomycin
The excitation wavelength == 275nm. Other conditions were
identical with those of Fig. 15A.
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Fig. 16 NaN02 quenching of phosphorescence of 76
cytochrome oxidase ± valinomycin
Phosphorescence spectra were obtained using a Perkin Elmer LS-
50 luminescence spectrometer and stored, using a McCOMP 386
computer with the FLDM data acquisition programme, for later
analysis. 7 JiM aa3 or 7JiM aa3 plus 10 JiM valinomycin was added
to a 1cm-lightpath, 3ml-volume fluorescence cuvette containing
50mM potassium phosphate, pH8.0 and 0.0150/0 lauryl maltoside.
The buffer had been bubbled with pure argon for 20 min to remove
the oxygen before being added to the cuvette, and a "oxygen trap"
composed of 80nM glucose oxidase , 20nM catalase and 0.050/0
glucose was also included. A layer of mineral oil was then put on
the. top of the deoxygenated solution to prevent it from contacting
the atmosphere. During subsequent measurements, aliquots of
NaN02 were added using a Hamilton syringe. The phosphorescence
emission spectra were measured using either 260nm or 295nm as
the excitation wavelength. The excitation spectra were recorded
using 460nm as the emission wavelength . The gate time was 3.0
ms , and the delay time was O.4ms. Both the excitation slit and
emission slit were 15.0nm. The experimental temperature was
4°C. Background contribution has been subtracted from all the
data. The Y axis unit is arbitrary.
decreased from 14°C to 4°C for the same reason; the decay of the
protein phosphorescence is much faster at higher temperatures
(Papp and Vanderkooi 1989). The delay time was increased from
0.2 ms to 0.4 ms to decrease the interference from the
fluorescence signal.
Since the concentration of aa3 is rather high (7J.:lM aa3
corresponds to about 1.4 mg/ml protein concentration), the
phos.phorescence excitation spectrum peak is no longer located at
275nm due to severe light reabsorption. So instead of using
275nm as the excitation wavelength, the two wavelengths 260nm
and 295nm , which correspond to artificial maxima in the
excitation spectrum, were used for excitation in emission
spectral scans. Fig.16 shows that when 295nm was used as the
excitation wavelength, the NaN02 quenching behaviour was not
changed by the presence of valinomycin. The percentage of
maximal quenching is 37%, while the quenching constant KD , the
reciprocal of the nitrite concentration required to have a half
maximal effect , is estimated as O.033J.lM-1.
On the other hand, when 260nm was used as the excitation
wavelength, the percentage of maximal quenching decreases from
34% to 140/0, while the quenching constantKD increases from
0.04 JlM-1 to 0.1 JlM-1 when valinomycin is present. The detailed
results are summarized in Table 3.
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Excitation
wavelength
260nm
295nm
I
Table 3
Additions
none
(control)
plus
valinomycin
none
(control)
plus
valinomycin
0.04
0.1
0.033
0.033
Maximum 0/0
quenching
340/0
140/0
Table 3. Nitrite quenching of phosphorescence of 78
cytochrome oxidase ± valinomycin
The apparent quenching constants listed in column three are the
reciprocals of the nitrite concentrations giving half maximal
effects. The quenching percentages listed in column four are the
maximal values reached at high nitrite concentrations. The
actual values in both columns are those used in the fits shown in
Fig. 16. The conditions are presented in the legend to Fig. 16.
Part II : Dibucaine-cytochrome oxidase interaction
A. Spectroscopic effects of dibucaine
Dibucaine contains a heterocyclic structure and two
hydrophobic chains:
Ci1 CH3
o =C • NHCH2CH2~CH2C~
The absorption spectrum of dibucaine(Fig.17A) shows that
it absorbs in the UV region(below 370nm) , but not in the visible
region . The chromophore is presumably the heterocyclic ring
which contains conjugated bonds. The absorption values at 290nm
and at 330nm increase linearly with dibucaine
concentr?tion(Fig.17B) , indicating that the Beer-Lambert law is
observed. The slope of the line, which represents the extinction
coefficient Em M, can be obtained by fitting the data to the
'Simple' function in the Cricket™ programme :
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EmM290nm = S.SOmM-1cm-1 and 80
EmM330nm = 7.80mM-1cm- 1
The above values are helpful in estimating concentrations of
dilute dibucaine solutions.
It has been reported that Ki for the dibucaine-oxidase
interaction is in millimolar range(Chazotte and Vanderkooi 1981 ;
Singer 1980,1982 and 1983; Stringer and Harmon 1990). At the
effective millimolar concentration range , dibucaine absorption in
the UV region (260nm-330nm) will be over S.OA based on the
extinction coefficients listed above . Since the excitation
wavelengths, for cytochrome c oxidase are located in this
region (Papp et al 1991), it is impossible to conduct an enzyme
fluorescence or phosphorescence study because of the severe
interference from the dibucaine absorption.
On the other hand, because dibucaine does not absorb in the
visible region (Fig.17A) , where the spectra of the metal centres
of cytochrome c oxidase are located, the dibucaine-induced
spectral changes of the enzyme can be studied
spectrophotometrically in a similar way to those of valinomycin.
Dibucaine induces a red shift of the enzyme's Soret peak
like that with valinomycin (Fig. 18). The difference spectra show
a progressive spectral change with time (Fig. 19). But unlike the
valinomycin-induced spectral shift(Fig. 6), the kinetic behaviour
of this spectral shift is more complicated . The isosbestic point
of the differen·ce spectra shifts with
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Fig. 17A. Absorption spectra of dibucaine. 8 1
Dibucaine concentrations between 6 and 42 11M, as indicated ·
Measurements in50mMpotassium phosphate, pH 7.4 and 0.0150/0
lauryl maltoside at 30°C. DU-7 Beckman spectrophotometer:
1cm-lightpath, 1ml-volume cuvette .
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Fig. 178 Absorbance change as a function of dibucaine 8 2
concentration :
Data from Fig. 17A. Buffer contribution to absorption is
subtracted from all the data. Conditions as in the legend to Fig.
17A. Conditions areas in the legend to Fig. 17A.
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Fig. 18 Absolute spectra of resting enzyme and dibucaine 83
-liganded enzyme.
Experiments in 50mMpotassium phosphate,pH 7.4, 0.0150/0 lauryl
maltoside at 30°C, with 4JlM resting enzyme..100jlM ferricyanide
was added to keep the enzyme in oxidized form. The spectrum
of the dibucaine-liganded species was taken 30 min after 2mM
dibucaine was added to the cuvette. DU-7 Beckman
spectrophotometer; 1cm-lightpath, 1ml-volume cuvette ·
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Fig.19 Difference spectra of dibucaine-liganded sp\ecies 8 4
minus resting enzyme.
Experiments in 50mM potassiumphosphate,pH 7.4, 0.0150/0 lauryl
maltoside at 30°C with 4JlM resting enz.yme . Spectra were taken
at 1Osee, 1min, 2min, 3·min,5min, 10min, 20min and30min after
addition of 1.5mM dibucaine . The spectrum of resting enzyme was
subtracted from each spectrum. DU-7 Beckman
spectrophotometer; a 1cm-lightpath, 1ml-volume quartz cuvette.
time , suggesting a multiphasic process · The peak was originally 8 5
located at 430nm, and then it slowly shifted to 436nm. The
trough stayed at 413nm. In this respect the dibucaine effect
differs from the valinomycin effect, which appears to result in a
single final species (Fig. 8A) . The rate of dibucaine binding was
studied by monitoring the spectral change at the 433-413nm
wavelength pair instead of 436nm-413nm (Fig. 20A), in order to
be consistent with the parallel study with valinomycin(Fig. 8A) .
When dibucaine was added to the enzyme, a biphasic trace was
obtained. The data were fitted to a double exponential rise
function in the Olis™ fitting programme. The values of the
maximal spectral change t1A and the rate constant kapp for the
fast phase can be calculated as 0.01 A and 0.019 sec- 1
respectively, while D.A andkapp for the slow phase are 0.07A and
0.00019 sec-1 . The corresponding logarithmic plot is shown in
Fig. 20(8). Assuming that kapp =-slope/log(e) = - 2.303 * slope,
the result is very close to that obtained by direct fitting.
Formate alone induced a opposite spectral shift to that with
dibucaine with a total D.A of 0.036. When formate was added after
dibucaine addition , the dibucaine-induced red shift was partially
reversed with a total t1A of 0.055 . The data were fitted to a
double exponential decay function in the OIiS™ fitting routines .
The corresponding logarithmic plots are shown in Fig. 20C. The
rate constants for the formate effect changed very little in the
presence of dibucaine, indicating that dibucaine does not hamper
formate binding at the binuclear centre .
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Fig. 20(A) Time course ofd'ibucainebinding to resting 8 6
cytochrome oxidase: comparison with fo,rmate binding.
Experiments in 50 mM potassium phosphate , pH7.4 ,0.0150/0
lauryl maltoside at 30°C with 1.5mM dibucaine or 3mM sodium
formate added to 5.0 JlM resting enzyme to start the reaction. At
the end of the dibucaine reaction , 3mM sodiu<m formate was also
added to compare the formate and dibucaine effects. Spectral
changes monitored at 433-413nm . DW-2 Otis d~al wavelength
spectrophotometer; 1cm-lightpath, 1ml-volume cuvette.

Fig. 20(8) Analysis of dibucaine binding kinetics 87
logarithmic plots of the differential absorbance changes.
Experimental data from the results in Fig. 20(A). The end point
(maximal absorbance change) was estimated using the Olis™
fitting routine for a double exponential rise function (see
Methods). Starting log(~Am-~A) arbitrarily set to 0.00. The
straight line shows the results of the fit to the chosen
experimental points (closed symbols). 1.5mM dibucaine plus 5.0Jl,M
resti ng enzyme at 30°C pH 7.4.
Fig. 20(C) Analysis of formate binding kinetics
logarithmic plots of the differential absorbance
ch anges(±d ibucaine).
Experimental data from the results(inverted from absorbance
decrease) in Fig. 20(A). The end points (maximal absorbance
changes) were estimated using the Olis™ fitting routine for a
double exponential rise function (see Met hod s). Starting
log(~Am-dA) arbitrarily set to 0.00. The straight line shows the
results of the fit to the chosen experimental points (closed
symbols: with dibucaine; open symbols: control). 3.0mM sodium
formate plus 5.0lJ.M resting enzyme at 30°C pH 7.4 ± dibucaine.
Other conditions as in the legend to Fig.20(A).
Fig.21 A plots the spectral changes at 433-413nm in 50mM 8 8
potassium phosphate buffer as a function of dibucaine
concentration . The dissociation constant Kd and the maximal
extinction coefficient ~EmMcan be obtain>ed from Eq. 12:
Kd = [E]*[D]/[ED] Eq.12
Since LlAmax = [E]tot*EmM, tiA=[ED]*EmM, and [E]tot=[E]+[ED],
we have:
1/liA = (Kd/LlAmax)I[D] + 1/~AmaxEq. 13
According to Eq. 13, a double reciprocal plot, Le. 1/tiA vs.
1/[0] will result in a straight line. The Y axis intercept is the
reciprocal of AAmax, which can be used to calculate AEmM. The X
axis in.tercept is the reciprocafof ;Kd. Fig. 21 Bshows that 1/AA
changes linearly with 1/[D]. The apparent dissociation constants
Kd and extinction coefficients AEmM can also be obtained by
fitting the data directly to an a'ppropriate "Binding" equation in
Multifit™(see Methods for detaifs).
The effect of ionic strength was investigated by monitoring
the spectral change at two different buffer concentrations(Fig.
22A). The apparent dissociation constants Kdand extinction
coefficients dE mM were obtainedu,sing the two methods
described above. Fig. 22Bis the double reciprocal plot of the data
from Fig. 22A.
The results from Figs. 21 and 22 are summarized in Table
4. The parameters obtained by ,direct fitting and from the double
reciproc,al plot are inessential agreement. Although the ionic
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Fig. 21 Effect of the dibucaine concentration on the 8 9
magnitude of the cytochrome oxidase spectral shift
Experiments in 50 mM potassium phosphate , pH7.4, 0.015% lauryl
maltoside at 30°C . Separate aliquots of 3.9 JiM enzyme were
incubated at the indicated dibucaine concentrations for 2 hours .
DU-7 Beckman spectrophotometer; 1cm-lightpath, 1ml-volume
cuvette .
A. titration curve(spectral change at 433-413nm)
B. double reciprocal plot(spectral change at 433-413nm)
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Fig. 22 Effect of ionic strength upon the dibucaine- 90
induced enzyme spectral shift
Two sets of experiments were carried out in 10 mM or 150mM
potassium phosphate , pH7.4, respectively, with 0.015% lauryl
maltoside at 30°C . Separate aliquots of 3.9 JlM enzyme were
incubated at the indicated dibucaine concentrations for 2 hours .
DU-7 Beckman spectrophotometer; 1cm-lightpath, 1ml-volume
cuvette .
A. Titration curve (spectral change at 433-413nm).
Open symbols : 150mM potassium phosphate.
Close symbols : 10mM potassium phosphate.
B. Double reciprocal plot (spectral change at 433-413nm).
Open symbols : 150mM potassium phosphate.
Close symbols : 10mM potassium phosphate.
By the dou<ble
reciprocal plotpotassiumphosphate
(mM)
Table 4
By direct
fitting
~E
(433-413nm) Kd (mM)
~E
(433-413nm)
10 * 0.47±0.07
7.51±O.5 8.23±0.7
-1 -1 O.56±O.08 -1-1
mM em mM em
50 # O.65±O.06 9.55~10._~6 O.62±O.07
mM em
9.40±0.4
- 1 - 1
mM em
150 * O.72±O.1 10.02±1.0 10.35±0.8
-1 -1 O.76±O.08 -1 -1
mM em mM em
* Values are from Fig. 22.
# Values are from Fig. 21.
Table 4. Dibucaine-induced spectral changes in the media 9 1
of different ionic strengths.
The values in the second row are obtained from the data of Fig.
21. The values in the first and third rows are obtained from the
data of Fig. 22. Columns two and three list the apparent
dissociation constants (Kd values) and maximal absorbance
changes obtained from the Multifit™ direct fitting routine.
Columns four and five list the corresponding dissociation
constants (Kd values) and maximal absorbance changes obtained
from the double reciprocal plots shown in Figs 218 and 228. All
conditions are listed in the legends to Figs. 21 and 22.
strength varied from 10mM potassi'um phosphate to 150mM 9 2
potassium phosphate , Kd and AEmM changed only slightly,
indicating that electrostatic forces are not the major factor
which determines the dibucaine -oxidase interaction.
The apparently similar spectral effects of dibucaine,
valinomycin and cyanide upon resting cytochrome oxidase(Figs.
4A, 5 and 18) prompted some parallel spectral studies under
enzymatic turnover conditions. To avoid complications from the
presence of cytochrome C J an artificial reducing system
compose:d of ascorbate plus TMPD was used. Ascorbate was added
in excess to keep the enzyme substrate TMPD com.pletely in its
colorless reduced form. 10 seconds after adding reducing
equivalents to the resting enzyme ,69 % of the cytochrome a
was reduced(Fig.23A), evidenced by a substantial absorption
increase at both 445nm and 604nm .In the later steady state(8
min after adding reducing equivalents), cytochrome a became
slightly reoxidized,indicating that the enzyme had become more
active . The 445nmband of the reduced enzyme is due to both a
and a 3 in roughly equalproportions(Yonetani 1960), so
cytochrome a3 remained mostly oxidized during the steady state
since the 445nmband developed to only about half o,f its possible
maximum . The 419nmbandmoved to 424nm during the steady
state. This phenomenon was explained by NichoUs and Hildebrandt
(1978a) as a high to low spin shift of the ferric 83 as a result of
a enzyme conformational cha'ngeduring the steady state. When
formate, a conventional ligand fo'r high spin haem a3, was added
to the resting enzyme, a blue shift of the Soret peak from 419nm
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Fig. 23A The early and late steady state behaviour of 9 3
cytochrome oxidase: control
The experiments were performed in 50mMpotassium phosphate,
pH 7.4, 0.015% laurylmaltosideat 30aC with 14 mMascorbate
plus 0.27 mM TMPD added to 3 llM oxidase ina 1cm-tightpath,
1ml-volume quartz cuvette. DU-7 Beckman spectrophotometer.
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Fig. 238. The early and ,late steady state behaviour of 9 4
cytochrome oxidase :in the presence of formate
14 mM ascorbate plus 0.27 mM TMPD were added to 3 JlM oxidase
in presence of 40mM formate, other conditions are identical as
those of Fig. 23A.
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Fig. 230 The early and late steady state behaviour of 9 6
cytochrome oxiidase : in the presence of valinomycin
14 mM ascorbate plus O.27mM TMPD were added to3 )lM oxidase
in presence of 4JlM valinomycin, other conditions are identical as
those of Fig. 23A.
to 417nm was seen(Fig. 238), indicating a low to high spin shift 97
of ferric 83 (Nicholls 1976) . Formate also kept cytochrome 83 in
the high spin form during the steady state, so that the 417nm
band remained at the same wavelength. A higher 605nm band and
a well-developed trough between the 417nm and 445nm bands
indicate that cytochrome a was much more reduced(>90% , see
Fig.24) during the formate-inhibited steady state compared with
control conditions, due to the inhibition of electron transfer
between cytochrome a and the binuclear center (Nicholls 1976).
In the presence of dibucaine(Fig. 23C) , the initial steady state
spectrum showed a higher 605nm band and a more marked split of
the 419nm and 445nm bands than in control conditions,
indicating inhibition of electron transfer. The later steady state
spectrum is similar to that in control conditions, and features a
decrease of absorption at both 605nm and 445nm as well as a red
shift of the Soret peak from 419nm to 424nm . The valinomycin
effect is similar to that of dibucaine (Fig. 230); a slight increase
in the steady state of cytochrome a was also seen, which is
consistent with the previous observations when the cytochrome a
steady state was monitored at the 605-630nm wavelength
pair(Fig. 12).
From the above experiments as summarized in Fig. 24, it is
clear that although both dibucaine and valinomycin have similar
effects upon the resting enzyme spectrum to those of
conventional low spin haem ligands such as cyanide and azide, the
two former ligands exhibit quite different spectral behaviour
during the steady state. Although they cause a slight increase in
Fig. 24
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Fig. 24. Cytochrome a steady states in the presence of 98
different ligands
Values are obtained from the sets of scanned spectra shown in
Fig. 23, using the differences between the absorbances at 604nm
and 630nm and calculating the percentage of reduced cytochrome
a by assuming that 85% of the t1.A after anaerobiosis is due to
reduced cytochrome a (Yonetani 1960). This summary figure
shows the results of a single set of experiments. Similar
experiments give similar results (steady state values differing
by no more than ± 50/0). All conditions are listed in the legends to
Fig. 23A, B, C and 0 .
the steady state of reduced cytochrome a, dibucaine and 9 9
valinomycin have no dramatic effects upon the steady state
pattern . On the other hand, the 419nm peak disappears in the
later steady state spectrum when <cyanide orazids is present
(Nicholls and Hildebrandt 1978a), and a smaU shoulder at 430nm
develops.
B. Kinetic effects of dibucaine
The inhibition of cytochrome oxidase activity by dibucaine
has been extensively studie,d bySin.ger(1980, 1982, 1983) using
an oxygen electrode technique. The inh·ibition can also be studied
by monitoring the cytochrome c redox steady state at 550-
540nm spectrophotometrically (Fig. 25). Employing a similar
method to that used to study inhibition by valinomycin , kr(see
Eq.4b) , the rate constant for reduction of cytochrome c by
ascorbate, is plotted against dibucaine concentration (Fig. 26A).
The value of krchanges very little with increasing dibucaine
concentration, suggesting that dibucaine does not inhibit
electron transfer between ascorbate and cytochrome c. The
progressive decrease in ko( the rate constant for oxidization of
ferrous cytochrome c by the enzyme ) with increasing dibucaine
concentration (F<ig. 26B) confirms the previous observation
(Singer 1980, Stringer and Harmon 1990) showing that dibucaine
is an oxidase inhibitor . This inhibition is not an artifact caused
by the artificial electron donor systems used in this and other
studies. The maximum percentage inhibition is approximately
80% , and the Ki , thecalcufated dibucaine concentration causing
Fig. 25
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Fig. 25. Effect of dibucaine upon steady state enzyme 100
activity.
The experiments were performed in 50 mM potassium phosphate,
pH=?.4, O.015%lauryl maltoside at 30°C . 12JlM cytochrome c and
1J,lM oxidase were incubated at the desired dibucaine
concentration(O-2.0mM) for 30 mins before adding 10mM
ascorbate to start the reaction. 1cm-lightpath , 1ml volume
quartz cuvette ; DW-2 dual wavelength spectrophotometer.
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Fig. 26. Kinetic analysis of the effects of dibucaine upon 101
the ascorbate-cytochrome c-cytochrome a83-02 steady
state.
A. Reduction of cytochrome c by ascorbate.
The second order reduction rate constants were calculated from
the steady state data of Fig. 25 according to the method described
on p. 65 of the Resu Its. The straight line is drawn for a constant
k r value of 68 M-1 s-1. Conditions are as in the legend of Fig.25.
Error bars are not shown .
B. Enzymatic activity (turnover).
The turnover number ko is the oxidation rate constant calculated
according to the method described on p.65 of the Results . The
theoretical curve is drawn for a Kd of O.7mM and a residual
activity of 20%. Conditions are as in the legend of Fig. 25. Error
bars are not shown.
half of maximal inhibition is estimated asO.7mM ( see fitted 102
curve, Fig. 26B).
The rate constant for cyanide binding is greatly enhanced
under enzymatic turnover conditions(Nicholls and Chance 1974).
Does the presence of reducing equiva,lents hay,s the same
accelerating effect on dibucaine binding with the enzyme? Fig.
27(A) shows that under turnover conditions, dibucaine causes a
biphasicincrease of cytochrome creduction in its steady state ,
with apparent rate constants of 0.08 1 and 0.0018 sec-1
730/0 of the rise is the fast phase, 270/0 stow phase.. These
data were obtained by fitting the to a double -exponential
rise function;n the OHsTMprogramme.. rate constants are
four times greater and ten times respectively than the
corresponding rate constants for the spectral shift. Since the
steady state of cytochrome c reflects the percentage of the
active enzyme (Nicholls and C'hance 1974), the rise in the reduced
cytochrome c steady state can be explained by grad<ual binding of
dibucaine to the enzyme. Theappare<nt rate constants obtained
above can thus be treated as thaapparent rate constants fo<r
dibucainebi,nding. So the of reducing equivalents indeed
increases the rate of dibucaine binding , in the case of cyanide
The corresponding logarithmic plot (Fig. 278) supports the
result of direct fitting. The maximal inhibiti,on is 80%. The
details of data transformation areinhod s.
The dibucainee·ffect upon electron transfer was
investig.atedby following the steadyspectrat change at the
445-470nm wavelength pair{Fig. 28). Whether the reducing
Fig. 27(A)
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Fig. 27(A). Fast and slow phases of dibucaine inhibition of 103
cytochrome oxidase
This experiment was carried out in 50 mM potassium phosphate,
pH 7.4, 0.0150/0 lauryl maltoside at 30°C with the DW-2 dual
wavelength spectrophotometer. 7.4 mM ascorbate was added to a
mixture of 85 nM aa3 and 13 JlM cyt. c in a 1cm-lightpath, 1ml-
volume quartz cuvette to start the reaction. 1.5 mM dibucaine was
then added during the steady state as indicated . Measurements
were made at the 550-540nm wavelength pair.
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Fig. 27(8) Kinetics of dibucaine inhibition monitored by 104
the cytochrome c steady state.
The experimental data are taken from the single set of results in
Fig. 27(A). The end point (final steady state cytochrome c
reduction) was estimated using the Olis™ fitting routine for a
double exponential rise function (see Methods). The changes of
uninhibited oxidase concentration ([E], closed symbols) with time
were calculated as described in Methods. The two straight lines
were drawn by hand to indicate two phases. Conditions are as in
the legend to Fig.27(A).
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Fig. 28A Effect of dibucai on steady state of 105
cytochrome oxidase : ascorbate + reductants
The experiments were conducted in 10mM potassium phosphate,
pH 7.4, O.015%laurylmaltosideat 30°C. 4JlM enzyme was
incubated in2mM dibucaine for 30min before 10mM ascorbate
plus O.4mM TMPD were added to the solution to start the
reaction. Measurements were at 445-470nm wavelength
pair. DW-2 dual wavelength spectrophotometer; 1cm-lightpath,
1ml-volumequartz cuvette; .
Fig. 28{B)
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Fig. 288 Effect of dibucaine on the steady state of 106
cytoc.hrome oxidase TMPD plus cytochrome c as
reductants
The experiments were conducted in 10mM potassium phosphate,
pH 7.4, O.015c/olauryl maltoside at 30°C. 4~fM enzym.e was
inc<ubated in 2mM dibucaine for 30min before 10mM ascorbate
plus 40JlM TMPD were added to the enzyme-cytochrome c
mixture to start the reaction. The cytochrome cconcentration
was 5JlM. Measurements were made 445...470nm waveiang.th
pair. DW-2. dual wavelength spectrophotometer; 1cm-lightpath,
1ml-volumequartzcuvette .
equivalents were ascorbate plus TMPD(Fig.28A),orcytochrome c 107
(Fig.28B), the presence of dibucaine caused a substantial rise of
steady state reduction at 445-470nm, indicating an increase in
the steady state amount of reduced cytoc.hrome a which in turn
suggests an inhibition of electron tra·nsfer between cytochrome a
and the binuclear center . But after anaerobiosis the spectral
change in the presence of a high concentrationofdibucaine(~2mM)
was very close to that undercontroJ conditions. Adding dithionite
had only a small additional affect. This indicated that both
cytochromes a an'd 83 were fully reduced after anaerobiosis. In
addition, unlike cyanide and form,ate (NicholfsandChanady 1982,
Nicholls 1976), there was no observable change o,f the reduction
rate of a3 monitored at anaerobiosis. This result is contrary to
the claim by Stringer and Harmon(1990) that dibucaine blocked
the reduction of a 3 completely but compatible with the
observation that the maximum percentage of inhibition by
dibuca'ine is800k(Fig. 268).
No perturbation of CUA was seen(Fig.29). When ascorbate
plus TMPD were the reducing equivalents(Fig.29A), CUA was
partially reduced during the steady state, which was evidenced by
a decrease of absorbance 830nm, the absorption band
attribu'te,d to cupric CUA(Nicholisand Chanady1982). The higher
steady state of cytochrome a and the prolonged anaerobiosis
time(100 seconds in the presence of dibucaine, compared with 52
seconds in control ,conditions) indicated that the electron
transfer between a and thebin'uctear center was inhibited. After
anaerobiosis, both cytochrome a and CUA werefuUy reduced in the
Fig. 29(A)
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Fig. 29AEffectof dibucaine on of a and 108
Cu A: TMPD is the reductant
The experiments were carried out in 50 mMpotassium phosphate,
pH 7.4, O.015°klaurylmaltoside 30°C. 11 mM ascorbate and
0.23 mM TMPD were added to 20llM resting enzyme or 20JlM
resting enzyme previousfyincubated in 1.0 mM dibucaine for 40
min. DW-2 dual wavelength spectrophotometer; 1,cm-lightpath,
1ml-volume quartz cuvette.
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Fig. 29BEffect of dibucaine on states Of8 and 109
C UA : cytochrome c is the reductant
The experiments were carried out in 50 mMpotassium phosphate,
pH 7.4, 0.015% lauryl maltoside at 30°C. 19.4 JlM cytochrome c
was mixed with 20JlM resting enzyme or 20 J,lMresting enzyme
previously incubated in 1.0mMdibucaine for 40 m'in. Then, 11 mM
ascorbate was added to the mixture to start the reaction. DW-2
dual wavelength spectrophotometer; 1cmMlightpath, 1ml-volume
quartz cuvette.
prese.nce of dibucaine, and adding dithionite had little further 11 0
effect. Whencytochromec was used{Fig.29B) , there was little
spectral change at 830nm duri.ng the steady state both in control
conditions and in the presence of dibucaine) indicating that CUA
remained mostly oxidized during a This phenomenon
was observed previouslyb·y Nicholls and Chanady (1982). On the
other hand, dibucaine greatly increased the steady state reduction
of cytochrome a , indicating a strong inhibition of electron
transfer between a and the binuclear center. After anaerobiosis,
CUA was again fully reduced in the presence of dibucaine, adding
dithionitehad little extra effect.
Based on the above observation, it that CUA is not the
51t90f dibucaine attack as Stringer and Harmon(1990) suggested.
All the experiments described so far have involved the
isolated enzyme, What about other forms of the en.zyme? Is the
conclusion drawn from the isolated enzyme still valid for the
enzyme in its physiological environment? To answer this
question, the dibucaine effect on cytochrome oxidase in
submitochondrial particles was tested(Fig. 30) .In
submitochondrial particles, the substrate for the enzyme,
cytochrome C , is inside the vesicles. Therefore TMPD, a
membrane-permeable reductant, is chosen as the source of
reducing equivalents. Ascorbate, the agent usually employed to
keep TMPD reduced, cannot reduce the oxidized TMPD trapped in
the membrane because it is membran>e-im.permeabfe. To solve this
problem and avoid the absorptio.n i·nterference from oxidized
TMPD(Wurstersblue), the submitochondrial particles were first
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incubated with 24 )lMantimycin( an inhib·itor of cytochrome blc1 113
complex, Cramer and Knaff1991 )to make sure that cytochrome c
would not be reduced by cytochrome b/c1complex. An axe,ess
(25mM) ,of succinate,a membrane-permeable reducing agent,
was then added to reduce the membrane bound TMPD. As it turned
out, similar to the results with isolated enzyme, dibucaine
increased the steady state of cytochrome a when monitored in
both the 445-470nm(Fig. 30A) and 604-630nm(Fig,. 30B) regions,
suggesting an inhibition of electron transfer betw·een
cytochrome a and the b'inuclear center. Dibucaine had little
effect upon the rate of as reduction when monitored at
anaerobiosis nor did it inhibit the re'd:uction of 83- The similarity
between this result and tho,seofexperiments with isolated
enzyme suggests that dibucaine has a similar effect upon isolated
enzyme and the en,zyme in submitochondrial particles as well .
Less marked steady state spectral changes in submitochondrial
particles induced bydibucaine(.Fig. 30) , as compared with the
isolatedenzyme(Fig. 28), is probably due to the fact that
dibucaine can bind other components of the respiratory chain
within submitoc·hondrial particles as weH as the o·xidase
(Chazotte and Vanderkooi 1981).
The severe scattering effects with submitochondrial
particles and the low abscorption at 830nm(LiEmM830~740nm= 1.0,
NichoHsandChanady 1982) make it very difficult to monitor the
CUA steady state with th,e submitochondrial 'particles.
The dib,ucaine effect on the enzyme kinetics in both high
and low ionic strength systems was also studied
Fig. 31
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Fig .31 Effect of dibucaine on &,,__o.xld'Else turnover 11 4
at high and low ionic strengths: Polarographic study
The experiments were carried out in 10mM KHEPES plus 70mM
K2S04 or 10mM KHEPES plus 4mM K2S04 ,pH 7.37, O.015%lauryl
maltoside at 30 a C with a Clark type oxygen electrode{Yellow
Springs Instruments). 25.6Jj.M EDTA, 3mMascorbate,O.174mM
TMPD, 0-1.5mM dibucaine, 51 nM cytochrome oxidase and
various concentrations of cytochrome casindicated were added
sequentially.
The turnover is calculated from the slo'pe of the oxygen electrode
traces. The mean turnover is shown with ± 1 standard deviation.
(0=3 ).
A. High ionic strength(10mMKHEPES plus 70mMK2S04).
B. Low ionic strength (10mM KHEPESplus 4mMK2S04 ).
polarogra.phically (fig. 31). To keep buffering constant, 10mM 115
KHEPES plus 70mM K2S04 or 4mM K2S04 were used instead of the
potassium phosphate buffer. Fig. 31 reveals that at a higher ionic
strength , the turnover number of the enzyme increases
hyperbolically with the cytochrome c concentration, while at a
lower ionic strength, a biphasic, non-hyperbolic rise is seen. This
general phenomenon has been explained by supposing that the
enzyme has two binding sites for cytochrome c (Cooper 1990),
one a "tight" site , and the other a "loose" site. At low ionic
strengths, both sites are catalytically functional , while at high
ionic strengths, only one binding site is catalytically functional .
Fitting the data from Fig. 31 with a Double Michaelis function in
the Multifit™ programme, the maximum velocities at the "tight"
site VmT and the "loose" site VmL can be obtained . Fig.32 shows
that even at high ionic strength(10mM KHEPES plus 70mM K2S04),
there is some activity at both binding sites . Perhaps the ionic
strength employed here was not high enough to eliminate fully
the biphasicity . Dibucaine has little effect on the VmT in both
high and low ionic strengths, but it decreases the
Vm(tot)(=VmT+VmL) substantially. Dibucaine does not affect KmT
and KmL at either high or low ionic strengths(Fig. 33). So
apparently dibucaine inhibits the "loose " binding site of the
enzyme non-competitively , decreasing VmL without affecting the
kinetics of the "tight " site .
Uncompetitive, noncompetitive and mixed types of
inhibition have been suggested for dibucaine-induced inhibition
(Singer 1982 & 1983, Casanovas et al 1983). Here I report a
Fig .32
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Fig.32 Dibucaine effect on Vmax values for cytochrome 116
oxidase at high and low ionic strengths.
V max values were obtained by fitting the data in Fig.31 to a
"Double Michaelis" function using the Multifit™ programme.
Error bars are not shown (but see Fig. 31).
Conditions as in Fig.31.
A. High ionic strength(10mM KHEPES plus 70mM K2S04).
B. Low ionic strength(10mM KHEPES plus 4mM K2S04).
noncompetitive inhibition of cytochrome oxidase activity by 11 7
dibucaine. It may be noted that an apparent uncompetitive
behaviour could be derived from results under biphasic binding
conditions where only the second phase is dibucaine-sensitive.
This may account for the earlier reports of uncompetitive and
mixed inhibition patterns.
The dibucaine-reconstituted cytochrome oxidase interaction
was also investigated polarographically (Fig. 34). When a low
concentration« 1mM) of dibucaine was added to the tightly
controlled cytochrome oxidase-contained proteoliposomes
(Fig. 34A) , a stimulation of the respiration rate was seen. The
dibucaine concentration causing half maximal stimulation is
estimated to be O.2mM. The respiration rate reached a saturating
level of 70JlM electron equivs. sec- 1 when the dibucaine
concentration exceeded 1mM. This can be best explained by the
~pH-dissipating effect of dibucaine, since dibucaine is a
membrane - permeable weak base. When the proteoliposomal
respiration was released by ionophores(FCCP plus valinomycin),
dibucaine caused a progressive decrease of the respiration rate
with a Ki = 0.4 mM , suggesting that in addition to the ionophore
effect, dibucaine also had an inhibition effect. The ionophore
effect of dibucaine is further supported by the decrease of the
respiratory control ratio in the presence of dibucaine(Fig.34B).
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Fig. 33 Dibucaine effect on Km values for cytochrome c 11 8
and cytochrome oxidase at high and low ionic strengths.
Km values were obtained by fitting the data in Fig.31 to a "Double
Michaelis" function using the Multifit™ programme. Error bars
are not shown (but see Fig. 31).
Conditions as in Fig.31.
A. High ionic strength (10mM KHEPES p<lus 70mM K2S04).
B. Low ionic strength (10mM KHEPES plus 4mM K2S04).
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Fig. 34 The dibucaine effect on the respiration of 119
reconstituted cytochrome oxidase .
Sets of experiments were carried out in 50mM potassium
phosphate, pH 7.37, at 30° C with a Clark type oxygen
electrode(Yellow Springs Instruments). 24JlM EDTA, 5.4mM
ascorbate, O.18mM TMPD ,12 nM reconstituted cytochrome
oxidase, and 24JlM cytochrome c were added. Dibucaine was
present at the indicated concentrations. The respiration rates
were calculated from the slopes of oxygen electrode traces. The
average respiration rates are shown ± 1 standard deviation
(n = 3). The respiratory control ratios were calculated as the
ratios between the control respiration rate and the respiration
rate after adding ionophores (1 J.lM valinomycin plus O.16JlM
nigericin).
A. Respiration rates plotted against
concentration.
Open triangles : uncontrolled rate(+ ionophores)
Closed circles : controlled rate (- ionophores)
Continuous lines: arbitrary exponential fits.
dibucaine
B . Respiratory control ratio plotted as a function of
dibucaine concentration .
Closed circles : ratios of rates from Fig. 34A .
Continuous line : exponential fit assuming the respiratory control
ratio equals 1 athign dibucaine concentrations.
DISCUSSION
Using spectrophotometric and oxygen electrode techniques,
the effects of valinomycin and dibucaine upon isolated
cytochrome c oxidase and cytochrome c oxidase in membrane
systems are investigated here. It is found that valinomycin and
dibucaine cause a similar but not identical red shift of the Soret
peak in the enzyme spectrum. In addition to their inhibitory
effects on the enzyme activity, valinomycin and dibucaine can
also act as ionophores in cytochrome oxidase containing vesicle
systems.
Valinomycin, in the form of its potassium complex, binds to
the isolated enzyme in some hydrophobic region of the protein.
This region may have some anionic character, as valinomycin-K+
can form quite specific complexes with hydrophobic anions
including the FCCP anion itself(O'Brien et al 1978). However, the
dependence on the presence of K+ is more likely due to a
conformational change of the valinomycin molecule structure
upon binding with K+ than to a involvement of electrostatic
forces (Fig. 9). The valinomycin molecule can assume different
conformations in different media (Ovchinnikov 1974). In non-
polar media, it assumes a compact symmetric structure with the
six carbonyl oxygen atoms pointing away from the centre; in polar
media, it assumes a flatter structure with the six carbonyl
oxygen atoms locating on one plane, forming a triangle(Fig. 38).
Upon binding the K+ ion, all the six carbonyl oxygen atoms become
120
liganded to theK+ at the centre ,forming an octahedral-like 121
shape with the oxygen atoms from the peptide bonds pointing
o>utwards. Probably these oxygen atoms from the peptide bonds as
well as the hydrophobic side chains are responsible for binding to
the enzyme. This site may be located somewhere near the
binuclear centre, as its occupancy causes the Soretband red
shift(an apparent high- to low- spin state change}. The effect is
distinct from that induced in 'pulsed' enzyme , and more similar
to the cyanide-induced change, although·of a smaller magnitude
by about 600/0. Like the cyanoenzyme, and unlike the 'pulsed' form,
the valinomycin-enzyme complex is inhibited. But unlike the
cyanide complex, the inhibition is incomplete. This inhibition
occurs with both isolated and vesicul·ar enzyme(Fig. 10, Fig. 13)
at a valinomycin concentration in the micromolar range.
Two effects occur at lower vatinomycinconcentrations(Fig.
13). These are the stimulation of flux in the absence of other
ionophores and the stimulation in the presen.ceof nigericin. The
former maybe due to the action of valinomycin as a proton
carrier(Hodarnauet al 1986). The fatter is presumably due to the
collapse of the controlling membrane potential (Wrigglesworth et
at. 1990).lti5 not the same as the effect on the isolated
oxidase. The stimulation occurs in thenanomolar range and is
clearly distinguished from the direct and partially inhibitory
effects (this thesis ,Steverding and Kadenbach 1990, Prochaska
and Wilson 1991).
The valinomycin-induced conformational change was also
studied by monitoring the protein fluores·cence and 122
phosphorescence. There are three amino acid reSidUeS(La/owicz
1983) which contribute to luminescence : tryptophan(trp),
tyrosine(tyr) and phenyla.lanine(phe). The emission from
phenylalanine is rarely observed because of its relatively low
absorption in the usual protein excitation wavelength range.
Tyrosine luminescence is also less common than that of
tryptophan, one reason being that energy can be transferred from
excited tyrosine residues to tryptophan residues. Above 295nm,
the absorption is due primarily to tryptophan. So tryptophan can
be selectively excited at 295,nm-305nm. I have sh,ownin Fig.
14 , valinomycin has some quenching effect on the enzyme
fluorescence , supporting th'e idea of a conformational change
induced by valinomycin. In addition, the nitrite quenching
behaviour was also altered in the presenceofvafinomycin for an
excitation wavelength of 260nm(Fig. 16). I propose that when the
excitation wavelength is 290nm, only tryptophan residues are
excited, valinomycin has little effect. At an excitation
wavelength of 260nm, some tyrosine residues are also excited.
Valinomy,cin causes a conformati·onal change of the protein
structure thatprevants the access toone part of these tyrosine
residues by the quenchernitrite; this results in a decreased
Qverallquenching of the phosphorescence signaf(Table 3) . On the
other hand, the quenching constant Koitselfincreases in the
presence of valinomycin , indicating that some residues become
more accessible to nitrite because of this valinomycin-induced
conformational change *
Comparison of the effects of dibucaine uponCOV systems
(Fig. 34) and upon the intact enzyme (Fig. 19 and 26) shows that
like valinomycin -K+ , there are two different typesot dibucaine
effect. Proteoliposomal activation requires 0.1 to O.5mM
anaesthetic while inhibition involves 0.5 to 5mM levels. The
rates are also different. The ionophore-like behaviour is rapid,
while the enzyme binding is s(ow,requiring tens of minutes or
even hours tor completion in the absence of turnover (Fig.20A).
Inhibition still requires significant to develop in actively
turning over system (Fig.27A). Most of my inhibitor studies
involved preincubation of the enzyme and the inhibitor. Similar
conclusions can be drawn from the results of Chazotte and
Vanderkooi (1981) who recognized stimulatory and inhibitory
concentration ranges.
Vanderkooi and Chazotte(1982} and Stringer and Harmon
(1990) , us,ed dibucaine to probe the oxidase mechanism . The
latter observed blockage of both ascorbate plus TMPD dependent
cytochrome aa reduction and ofCuA reduction with normal
cytochrome c depleted beef heart mitochondria . Inhibitors that
block cytochrome as reduction, 5uchas cyanide, promote
reduction of CUA; and inhibitors of CUA reduction normally have
no effect upon the binuclear 83C uS ce,ntre. In the present
experiments, low concentrationsofdibucaine«5mM) were found
to inhibit the enzyme by interfering with electron transfer
between cytochrome a and the binuclear centre. The steady
states ofCuA were little affected by the presence of dibucaine,
123
and the anaerobic transition of the cytochrome a 3 was 124
kinetically very similar to the transition in the controls. So the
attack site of dibucaine apparently is the electron transfer
between cytochrome a and the binuclear centre , not the CUA
centre as Stringer and Harmon (1990) suggested.
That the dibucaine-cytochrome oxidase interaction is
kinetically reversible has been demonstrated by several authors
(Vanderkooi and Chazotte 1982, Grouselle et al 1990). Although I
have not directly examined such reversibility spectroscopically,
the results described here suggest that, like the kinetic effects,
the spectroscopic ones are also reversible. On the other hand,
there is no mention in the literature of the reversibility of
valinomycin-cytochrome oxidase interaction, but, judged from its
relatively small maximal effect upon the oxidase activity, and
from its adherence to the binding equation, presumably this
process is also a reversible one. Although valinomycin and
dibucaine cause superficially similar spectral shifts of the
enzyme to those caused by conventional ligands such as cyanide,
the interactions are fundamentally different. The differences are:
(i) both are large amphiphilic molecules which bind the protein
structure instead of haem groups ; (ii) the changes are less
marked than with cyanide; (iii) unlike cyanide, only partial
inhibition is achieved; and, (iv) no dramatic spectral changes are
seen during steady state reduction in the presence of these
substances (Fig. 23) while cyanide , azide and formate cause
marked spectral changes during turnover .
ValinomycinK+- and dibucaine-oxidase interactions are
probably analogous (cf. Steverding and Kadenbach 1990). In both
cases an amphiphilic monocation interacts with the enzyme in a
region distinct from the binuclear centre and the cytochrome c
binding site. Dibucaine does not affect formate binding, which
occurs equally with free and dibucaine-bound enzyme; formate
can bind to either resting or 'pulsed' enzyme to give a complex
almost indistinguishable from the 'high-spin' resting form (Moody
at at 1991; Schoonover and Palmer 1991). The final valinomycin
or dibucaine complex has a modified Soret peak and shows
diminished but not zero activity. The spectral change induced by
valinomycin is the more marked, but valinomycin is less effective
in inhibiting the enzyme. These spectral and kinetic effects
identify an enzyme site which influences electron transfer
between cytochrome a and the cytochrome a3 CUB centre.
Somewhere between cytochrome a and the binuclear centre lies a
hydrophobic and perhaps anionic site that can bind fairly large
species so that the resting a3 CUB spectrum is modified and
electron transfer slowed (cf. ATP binding, Bisso,n et at 1987).
The exact location of this site is difficult to determine from
currently available knowledge. Subunit III is known to be
somehow related to proton pumping activity (Brunori et al 1987;
Prochaska and Fink 1987 ), and" it is easy to deplete the enzyme
of subunit III (Cooper et at 1991). The depleted enzyme shows a
red-shifted Soret peak (Tihova at al 1992 ). Sone and Nicholls
(1984) reported that after heating the oxidase to 43.5°C , the
125
enzyme lost H+ -pumping capability without affecting turnover. 126
These authors could not rule out the possibility of a functional
dissociation of subunit III. The Soret peak of heated cytochrome
oxidase was also red shifted. Such red shifts of the Soret peak
are related to dissociation or damage to subunit III. Dibucaine
causes a partial dissociation of the F1 complex (Chazotte, et al
1982). It is thus possible that dibucaine, and perhaps valinomycin
as well, binds at the interface of Subunits I and III, causing a
partial dissociation of subunit III from the rest of the enzyme,
which in turn triggers a conformational change of the whole
enzyme structure. The major aspects of valinomycin- and
dibucaine- oxidase interactions are summarized in Table 5, to
allow comparisons to be made.
I propose the scheme for valinomycin and dibucaine
inhibition in Fig. 35, to compare with other inhibitors of
cytochrome oxidase. Hill(1991) cl~ims that the CUA site is
probably the first acceptor of electrons entering from
cytochrome c. Polylysine competes with cytochrome c for the
binding site on subunit II, thus inhibiting the reduction of CUA by
cytochrome c . Cyanide , azide and formate are ligands of the
binuclear centre, so they inhibit entrance of electrons into that
centre. Carbon monoxide occupies the dioxygen binding site
(Nicholls and Chance 1974) , thus inhibiting the reoxidation of the
binuclear centre. Finally, valinomycin and dibucaine cause a
conformational change of subunit I, diminishing the rate of the
electron transfer between cytochrome a and the binuclear centre.
Table 5
lonophore
iMaximum ~.ffect
concen-
inhibition: ration
Ki
~ype
· AEmM~. KdLigand I. . ..(.Wit.. h restingllnhibition
433-413nm • nzyme)
(mM-1 cm -1)
Valinomycir 22 non-12. 5 -3. 0 J-lMI·. .. I 1.01lM
com petltlve 55% 1< O.05JlM
,Dibucaine 9.5
non-
O.65mM I tOt" I O.7mMicompe··I.lve 800/oI0.1-0.5mM
Table. 5 Comparison of valinomycin- and dibucaine- 127
cytochrome c oxidase interactions.
The values listed summarize the results shown in Figs. 7, 11, 21
and 26. The conditions in each case are listed in the legends to
these figures.
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Fig. 35. A scheme for inhibition transport 128
through cytochromec oxidase tomolec'ularoxygen.
CONCLUSIONS
(1) Valinomycin-K+ complex binds with the isolated cytochrome c
oxidase with a Kd in the micromolar range, causing a red shift of
the Soret peak in the enzyme spectrum and a maximal 55%
inhibition of the enzyme activity.
(2) The membrane potential dissipating ability of valinomycin
saturates at a much lower concentration« O.05JlM) than required
to cause an inhibition.
(3) Dibucaine binds with the isolated cytochrome c oxidase with
a Kd ~ O.5mM, causing a biphasic red shift of the Soret peak and a
maximal 800/0 inhibition of the enzyme activity.
(4) Dibucaine acts as an ionophore in the concentration range of
O.1-0.5mM , and it acts as an enzyme inhibitor at the O.5mM to
5mM levels.
(5) Both valinomycin and dibucaine inhibit cytochrome c oxidase
non-competitively by causing a conformational change of the
protein structure which modifies the spectrum of the a 3 CUB
centre and diminishes the rate of electron transfer between
cytochrome a and the binuclear centre.
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